Term,Overlap,P.value,Adjusted.P.value,Old.P.value,Old.Adjusted.P.value,Odds.Ratio,Combined.Score,Genes
Defense Response To Symbiont (GO:0140546),25/148,2.32866869710218e-32,1.54390734617875e-29,0,0,57.4390243902439,4183.71070267594,IFITM1;IFI6;DDX60L;IFIT1;DDX60;IFIT3;IFI44L;IFIT2;OASL;GBP2;GBP5;RSAD2;STAT1;MX2;MX1;EIF2AK2;ISG15;NT5C3A;PLSCR1;OAS1;IFI27;OAS2;OAS3;IRF7;TLR7
Defense Response To Virus (GO:0051607),26/189,3.33322819375383e-31,1.1049651462294e-28,0,0,45.6381257224149,3202.71008410375,IFITM1;IFI6;DDX60L;IFIT1;DDX60;USP18;IFIT3;IFI44L;IFIT2;OASL;GBP2;GBP5;RSAD2;STAT1;MX2;MX1;EIF2AK2;ISG15;NT5C3A;PLSCR1;OAS1;IFI27;OAS2;OAS3;IRF7;TLR7
Negative Regulation Of Viral Process (GO:0048525),12/61,9.24859022392453e-17,2.04393843948732e-14,0,0,58.5866732235063,2162.98924372637,IFITM1;PLSCR1;RSAD2;OAS1;OAS2;STAT1;OAS3;MX1;EIF2AK2;ISG15;IFIT1;OASL
Negative Regulation Of Viral Genome Replication (GO:0045071),11/53,9.88541450841964e-16,1.63850745477056e-13,0,0,61.9311224489796,2139.7389280168,IFITM1;PLSCR1;RSAD2;OAS1;OAS2;OAS3;MX1;EIF2AK2;ISG15;IFIT1;OASL
Regulation Of Viral Genome Replication (GO:0045069),11/67,1.57898870071782e-14,2.09373901715182e-12,0,0,46.4156037414966,1475.06034957802,IFITM1;PLSCR1;RSAD2;OAS1;OAS2;OAS3;MX1;EIF2AK2;ISG15;IFIT1;OASL
Interleukin-27-Mediated Signaling Pathway (GO:0070106),5/5,2.17310877417682e-12,2.40128519546539e-10,0,0,99525,2672730.17625576,OAS1;OAS2;STAT1;MX1;OASL
Response To Cytokine (GO:0034097),10/125,4.075423138898e-10,3.86000791584196e-08,0,0,20.2455242966752,437.72597747699,IFITM1;PLSCR1;STAT1;LAMP3;MX2;MX1;EIF2AK2;ISG15;IL6ST;XAF1
Antiviral Innate Immune Response (GO:0140374),7/46,2.0052848600154e-09,1.66187982773776e-07,0,0,40.5192307692308,811.49807215469,OAS1;MX1;EIF2AK2;IFIT1;USP18;IFIT3;IFIT2
Regulation Of Ribonuclease Activity (GO:0060700),4/5,2.37923203961973e-09,1.7527009358532e-07,0,0,874.901098901099,17372.4632360506,OAS1;OAS2;OAS3;OASL
Regulation Of Nuclease Activity (GO:0032069),4/6,7.11185516924085e-09,4.71515997720668e-07,0,0,437.428571428571,8206.81732532374,OAS1;OAS2;OAS3;OASL
Positive Regulation Of Interferon-Beta Production (GO:0032728),6/36,1.69921493637757e-08,1.0241631843803e-06,0,0,44.6629213483146,799.042637603324,OAS1;OAS2;OAS3;IRF7;ISG15;TLR7
Positive Regulation Of Type I Interferon Production (GO:0032481),7/64,2.17142062178722e-08,1.19970989353744e-06,0,0,27.6985645933014,488.749457614655,OAS1;OAS2;STAT1;OAS3;IRF7;TLR7;ISG15
Regulation Of Interferon-Beta Production (GO:0032648),6/50,1.31417133701972e-07,6.7022738188006e-06,0,0,30.4305413687436,482.168560724375,OAS1;OAS2;OAS3;IRF7;TLR7;ISG15
Response To Interferon-Beta (GO:0035456),5/29,2.35881356508533e-07,1.11706670975112e-05,0,0,46.0208333333333,702.275012061264,IFITM1;PLSCR1;OAS1;STAT1;XAF1
Negative Regulation Of Type I Interferon-Mediated Signaling Pathway (GO:0060339),4/15,6.26336752350904e-07,2.768408445391e-05,0,0,79.4965034965035,1135.47858268099,OAS1;OAS3;ISG15;USP18
Cellular Response To Type I Interferon (GO:0071357),5/38,9.63922685698076e-07,3.9942546288614e-05,0,0,33.4545454545455,463.420886085141,IFITM1;IFI27;STAT1;OAS2;IFIT1
Response To Interferon-Alpha (GO:0035455),4/17,1.0841549192128e-06,4.22820418492993e-05,0,0,67.2595097210482,923.789843996692,IFITM1;MX2;LAMP3;EIF2AK2
Response To Type II Interferon (GO:0034341),6/80,2.21654310340207e-06,8.16426709753095e-05,0,0,18.0665047069541,235.217973392147,GBP5;IFITM1;STAT1;GBP2;GBP1;GBP4
Response To Type I Interferon (GO:0034340),3/9,8.54196781324796e-06,0.000298069718957021,0,0,108.146739130435,1262.12859042222,MX1;ISG15;IFIT1
Cellular Response To Type II Interferon (GO:0071346),5/66,1.54538211506194e-05,0.000504148119566309,0,0,18.0728597449909,200.204891772228,GBP5;STAT1;GBP2;GBP1;GBP4
Cellular Response To Cytokine Stimulus (GO:0071345),9/308,1.5968492474951e-05,0.000504148119566309,0,0,6.86217624640274,75.792002371529,GBP5;OAS1;STAT1;IFIT1;IL6ST;GBP2;GBP1;TNFRSF21;GBP4
Regulation Of Type I Interferon-Mediated Signaling Pathway (GO:0060338),4/33,1.7586437244459e-05,0.000529991267867105,0,0,30.1265630920803,329.837138073706,OAS1;OAS3;ISG15;USP18
Type I Interferon-Mediated Signaling Pathway (GO:0060337),4/37,2.79749883131299e-05,0.000806409445721962,0,0,26.4695304695305,277.511843977617,IFITM1;IFI27;STAT1;OAS2
Positive Regulation Of Pattern Recognition Receptor Signaling Pathway (GO:0062208),4/39,3.45872474564942e-05,0.000955472710985653,0,0,24.9544740973312,256.332994627742,RSAD2;IFI35;DDX60;OASL
Positive Regulation Of Immune Response (GO:0050778),5/80,3.94496116556167e-05,0.00104620370110696,0,0,14.6888888888889,148.952477343261,GBP5;PLSCR1;RSAD2;IFI35;IL6ST
Defense Response To Protozoan (GO:0042832),3/15,4.53216089580868e-05,0.00115570102843121,0,0,54.0570652173913,540.663988198473,GBP2;GBP1;GBP4
Defense Response To Bacterium (GO:0042742),7/204,5.36206509983804e-05,0.00131668487451578,0,0,7.95777572681126,78.2533946626964,OAS1;OAS2;OAS3;ISG15;GBP2;GBP1;GBP4
Interferon-Mediated Signaling Pathway (GO:0140888),4/49,8.59193560094632e-05,0.00203444760836693,0,0,19.3992673992674,181.617908913483,IFITM1;IFI27;OAS2;STAT1
Negative Regulation Of Innate Immune Response (GO:0045824),4/52,0.000108595379493918,0.00248271505532646,0,0,18.1840659340659,165.982002625077,OAS1;OAS3;ISG15;USP18
Positive Regulation Of Chemokine Production (GO:0032722),4/53,0.000117035084302142,0.00258647536307733,0,0,17.8120654855349,161.253284365294,OAS1;OAS3;EIF2AK2;TLR7
Positive Regulation Of Interferon-Alpha Production (GO:0032727),3/21,0.000129768109909876,0.00277536312484669,0,0,36.0271739130435,322.434612968762,STAT1;IRF7;TLR7
Negative Regulation Of Cytokine-Mediated Signaling Pathway (GO:0001960),4/59,0.000177988917591739,0.00368770788635385,0,0,15.8641358641359,136.96760600685,OAS1;OAS3;ISG15;USP18
Regulation Of Interferon-Alpha Production (GO:0032647),3/26,0.000249353413549307,0.00500973676312698,0,0,28.1880907372401,233.86642242508,STAT1;IRF7;TLR7
Regulation Of Innate Immune Response (GO:0045088),4/78,0.000520762598619084,0.0101548706730721,0,0,11.7796257796258,89.056518649111,GBP5;PLSCR1;IFI35;PARP9
Positive Regulation Of Monocyte Chemotactic Protein-1 Production (GO:0071639),2/8,0.000613586182064546,0.0116230753916798,0,0,71.3225806451613,527.515345447086,OAS1;OAS3
Apoptotic Process (GO:0006915),6/228,0.000767618504359596,0.0140924624436521,0,0,5.97722441542666,42.8699546735682,PLSCR1;IFI27;MX1;IFI6;TNFRSF21;IFIT2
Positive Regulation Of RIG-I Signaling Pathway (GO:1900246),2/9,0.000786457180113315,0.0140924624436521,0,0,61.1305683563748,436.959608105148,DDX60;OASL
Regulation Of RNA Metabolic Process (GO:0051252),4/91,0.000930974665076005,0.0162430579722471,0,0,10.0128836680561,69.882703643887,OAS1;OAS2;OAS3;OASL
Positive Regulation Of Response To Biotic Stimulus (GO:0002833),3/41,0.000970996633174966,0.0165069427639744,0,0,17.0483409610984,118.267538783814,GBP5;PLSCR1;IFI35
Regulation Of B Cell Proliferation (GO:0030888),3/44,0.00119401884299587,0.0193097284410125,0,0,15.7985153764581,106.330809471635,CD38;TNFRSF21;TNFSF13B
Regulation Of Monocyte Chemotactic Protein-1 Production (GO:0071637),2/11,0.00119411593677453,0.0193097284410125,0,0,47.5412186379928,319.96900136532,OAS1;OAS3
Positive Regulation Of Innate Immune Response (GO:0045089),3/45,0.00127492749621856,0.0201256411903073,0,0,15.4215838509317,102.7827893761,GBP5;PLSCR1;IFI35
Cytokine-Mediated Signaling Pathway (GO:0019221),6/257,0.00142160301900199,0.0215250820529394,0,0,5.27883969739021,34.6079155221118,OAS1;OAS2;STAT1;MX1;IL6ST;OASL
Regulation Of Chemokine (C-X-C Motif) Ligand 2 Production (GO:2000341),2/12,0.00142851223277426,0.0215250820529394,0,0,42.7849462365591,280.289392845244,OAS1;OAS3
Regulation Of ERBB Signaling Pathway (GO:1901184),2/13,0.00168302776094278,0.0242575522935883,0,0,38.8934506353861,248.418725958488,MVB12B;IFI6
Endolysosomal Toll-Like Receptor Signaling Pathway (GO:0140894),2/13,0.00168302776094278,0.0242575522935883,0,0,38.8934506353861,248.418725958488,OAS1;TLR7
Positive Regulation Of NIK/NF-kappaB Signaling (GO:1901224),3/53,0.00204786142294354,0.0288879175193951,0,0,12.9489130434783,80.1661928372895,EIF2AK2;TLR7;IFI35
Regulation Of Monocyte Differentiation (GO:0045655),2/15,0.00225164845488082,0.0311008942830413,0,0,32.9065343258892,200.601283173228,CDK6;IRF7
Cellular Response To Tumor Necrosis Factor (GO:0071356),4/119,0.00250052731455333,0.0333498480845687,0,0,7.56426182513139,45.319411220421,STAT1;GBP2;GBP1;TNFRSF21
Regulation Of Nucleocytoplasmic Transport (GO:0046822),2/16,0.00256537292958221,0.0333498480845687,0,0,30.5545314900154,182.277684148777,IFI27;MX2
Negative Regulation Of Chemokine Production (GO:0032682),2/16,0.00256537292958221,0.0333498480845687,0,0,30.5545314900154,182.277684148777,OAS1;OAS3
Regulation Of Hematopoietic Progenitor Cell Differentiation (GO:1901532),2/17,0.00289845523849149,0.0362960619577291,0,0,28.5161290322581,166.636206016138,MYB;EIF2AK2
Positive Regulation Of Defense Response (GO:0031349),4/124,0.00290149514895874,0.0362960619577291,0,0,7.24725274725275,42.3422851161243,GBP5;PLSCR1;TLR7;IFI35
Regulation Of RIG-I Signaling Pathway (GO:0039535),2/18,0.00325070833872799,0.0384860647960118,0,0,26.7325268817204,153.147501584261,DDX60;OASL
Regulation Of Adaptive Immune Response (GO:0002819),2/18,0.00325070833872799,0.0384860647960118,0,0,26.7325268817204,153.147501584261,IRF7;IL6ST
Response To Organophosphorus (GO:0046683),2/18,0.00325070833872799,0.0384860647960118,0,0,26.7325268817204,153.147501584261,STAT1;TLR7
Regulation Of Toll-Like Receptor Signaling Pathway (GO:0034121),2/20,0.00401198527004054,0.0466657234041558,0,0,23.7598566308244,131.118034171101,GFI1;IRF7
Protein Localization To Organelle (GO:0033365),4/137,0.00414542047159246,0.0473864443563069,0,0,6.53457820375114,35.8470692743318,GBP5;ISG15;GBP2;GBP1
Positive Regulation Of Cytokine Production (GO:0001819),6/320,0.00422605962611952,0.0474894496969024,0,0,4.20618335361053,22.9930392635633,GBP5;IRF7;EIF2AK2;TLR7;ISG15;IL6ST
Negative Regulation Of Epithelial Cell Proliferation (GO:0050680),3/70,0.00451525436775829,0.0498935607637291,0,0,9.65509409474367,52.1403443469312,CDK6;STAT1;BRCA2
Negative Regulation Of Myeloid Cell Differentiation (GO:0045638),2/22,0.0048477333782795,0.0518394714483759,0,0,21.3817204301075,113.948405909596,CDK6;MYB
Cellular Response To Interferon-Beta (GO:0035458),2/22,0.0048477333782795,0.0518394714483759,0,0,21.3817204301075,113.948405909596,OAS1;STAT1
Positive Regulation Of Lymphocyte Proliferation (GO:0050671),3/74,0.00527461517919734,0.0548330033394334,0,0,9.10930802204532,47.7769501175115,CD38;IL6ST;TNFSF13B
Cytosolic Pattern Recognition Receptor Signaling Pathway (GO:0002753),2/23,0.00529308026202676,0.0548330033394334,0,0,20.3625192012289,106.72719024813,OAS3;IRF7
Gliogenesis (GO:0042063),2/24,0.00575650285139189,0.0578266877344367,0,0,19.435972629521,100.239573714392,CDK6;HAPLN3
Response To Purine-Containing Compound (GO:0014074),2/24,0.00575650285139189,0.0578266877344367,0,0,19.435972629521,100.239573714392,STAT1;TLR7
Regulation Of Immune Response (GO:0050776),3/77,0.00589156494016672,0.0583001127661274,0,0,8.73868977673325,44.8664748655357,PLSCR1;RSAD2;IRF7
Positive Regulation Of Tumor Necrosis Factor Production (GO:0032760),3/78,0.00610639774565716,0.0595373780201573,0,0,8.62173913043478,43.9572321005266,OAS1;OAS2;OAS3
Positive Regulation Of Response To External Stimulus (GO:0032103),4/155,0.0064008387415978,0.0615037113866572,0,0,5.75038206826286,29.0470558534576,GBP5;PLSCR1;TLR7;IFI35
Negative Regulation Of Catalytic Activity (GO:0043086),2/26,0.00673686416167672,0.0638077277027381,0,0,17.8145161290323,89.0754437983877,IFIT1;PARP9
Positive Regulation Of Tumor Necrosis Factor Superfamily Cytokine Production (GO:1903557),3/82,0.00701233177988915,0.0654813516910776,0,0,8.18354430379747,40.5910753237852,OAS1;OAS2;OAS3
Regulation Of NIK/NF-kappaB Signaling (GO:1901222),3/83,0.00725058748594859,0.06676582643311,0,0,8.08084239130435,39.8116662556093,EIF2AK2;TLR7;IFI35
Regulation Of Osteoblast Differentiation (GO:0045667),3/85,0.00774138641369077,0.0697709646597935,0,0,7.88295334040297,38.3204116385478,IFITM1;CDK6;IL6ST
Positive Regulation Of Defense Response To Virus By Host (GO:0002230),2/28,0.00778740782024845,0.0697709646597935,0,0,16.4425144747725,79.8324728878795,STAT1;PARP9
Positive Regulation Of B Cell Proliferation (GO:0030890),2/29,0.0083385629827294,0.0737128967673279,0,0,15.8327359617682,75.7891598400376,CD38;TNFSF13B
Regulation Of Cell Population Proliferation (GO:0042127),9/766,0.010590729917442,0.0922322798802412,0,0,2.64710761574145,12.0384530046659,IFITM1;CDK6;IRS1;STAT1;EIF2AK2;SGK3;IFI35;IL6ST;IFIT3
Regulation Of NLRP3 Inflammasome Complex Assembly (GO:1900225),2/33,0.0107117429121849,0.0922322798802412,0,0,13.7870274020118,62.5436733740904,GBP5;EIF2AK2
Apoptotic Mitochondrial Changes (GO:0008637),2/34,0.0113463334408073,0.0957257807222741,0,0,13.3555107526882,59.8174713319068,IFI6;IFIT2
Positive Regulation Of Protein-Containing Complex Assembly (GO:0031334),3/98,0.011406239331915,0.0957257807222741,0,0,6.79977116704806,30.4194206857955,GBP5;ISG15;GBP2
Regulation Of G2/M Transition Of Mitotic Cell Cycle (GO:0010389),2/35,0.0119971086556647,0.0994260379838212,0,0,12.950146627566,57.2796589133196,CDK6;TNFSF13B
Regulation Of Erythrocyte Differentiation (GO:0045646),2/36,0.0126639038591974,0.103656398254912,0,0,12.5686274509804,54.9123276534933,CDK6;STAT1
Modification-Dependent Protein Catabolic Process (GO:0019941),4/192,0.0133050964163919,0.105620748688535,0,0,4.61000701426233,19.9134237687153,HERC5;ISG15;TNFSF13B;HERC6
Regulation Of Defense Response To Virus By Host (GO:0050691),2/37,0.0133465555258617,0.105620748688535,0,0,12.2089093701997,52.6997199429551,STAT1;PARP9
Positive Regulation Of Inflammatory Response (GO:0050729),3/104,0.0133818143134796,0.105620748688535,0,0,6.39388721480844,27.5823255700041,TLR7;IFI35;IL6ST
Response To Peptide (GO:1901652),2/38,0.0140449012921475,0.109550230078751,0,0,11.8691756272401,50.6279193384414,IRS1;STAT1
Negative Regulation Of Protein Secretion (GO:0050709),2/39,0.0147587799477585,0.112790420089893,0,0,11.5478058703865,48.6845924973337,RSAD2;IRS1
Response To Tumor Necrosis Factor (GO:0034612),3/108,0.0148005528624746,0.112790420089893,0,0,6.14906832298137,25.9065828317006,GBP2;GBP1;TNFRSF21
Regulation Of Chemokine Production (GO:0032642),2/41,0.016232496842391,0.122297106892105,0,0,10.9545078577337,45.1406794557401,EIF2AK2;TLR7
Negative Regulation Of BMP Signaling Pathway (GO:0030514),2/43,0.0177664394055573,0.132349992425668,0,0,10.4190925780226,41.99356945819,GPR155;SKIL
Positive Regulation Of Osteoblast Differentiation (GO:0045669),2/44,0.018555604373891,0.13519083186692,0,0,10.1705069124424,40.5496423614738,IFITM1;IL6ST
Positive Regulation Of Cytokine-Mediated Signaling Pathway (GO:0001961),2/44,0.018555604373891,0.13519083186692,0,0,10.1705069124424,40.5496423614738,GFI1;PARP9
Regulation Of Epidermal Growth Factor Receptor Signaling Pathway (GO:0042058),2/46,0.0201775495838105,0.138418245758626,0,0,9.70723362658847,37.8891257646799,MVB12B;IFI6
Regulation Of Interleukin-10 Production (GO:0032653),2/46,0.0201775495838105,0.138418245758626,0,0,9.70723362658847,37.8891257646799,ISG15;TNFRSF21
Insulin Receptor Signaling Pathway (GO:0008286),2/47,0.0210100242985833,0.138418245758626,0,0,9.4910394265233,36.6615657667672,IRS1;GAB1
Regulation Of Tumor Necrosis Factor Production (GO:0032680),3/127,0.0226668262377697,0.138418245758626,0,0,5.20187587657784,19.6987383460197,OAS1;OAS2;OAS3
Neurogenesis (GO:0022008),2/49,0.022717222354827,0.138418245758626,0,0,9.08625028597575,34.388113120849,CDK6;BTBD3
Negative Regulation Of Cysteine-Type Endopeptidase Activity Involved In Apoptotic Process (GO:0043154),2/49,0.022717222354827,0.138418245758626,0,0,9.08625028597575,34.388113120849,LAMP3;IFI6
CD4-positive, Alpha-Beta T Cell Activation (GO:0035710),1/5,0.02352761014601,0.138418245758626,0,0,52.9281914893617,198.458522523967,RSAD2
Establishment Of Protein Localization To Telomere (GO:0070200),1/5,0.02352761014601,0.138418245758626,0,0,52.9281914893617,198.458522523967,BRCA2
Positive Regulation Of Interleukin-18 Production (GO:0032741),1/5,0.02352761014601,0.138418245758626,0,0,52.9281914893617,198.458522523967,GBP5
ISG15-protein Conjugation (GO:0032020),1/5,0.02352761014601,0.138418245758626,0,0,52.9281914893617,198.458522523967,ISG15
Negative Regulation Of Myeloid Cell Apoptotic Process (GO:0033033),1/5,0.02352761014601,0.138418245758626,0,0,52.9281914893617,198.458522523967,IRF7
Negative Regulation Of Nervous System Process (GO:0031645),1/5,0.02352761014601,0.138418245758626,0,0,52.9281914893617,198.458522523967,TNFRSF21
Regulation Of Hematopoietic Stem Cell Proliferation (GO:1902033),1/5,0.02352761014601,0.138418245758626,0,0,52.9281914893617,198.458522523967,EIF2AK2
T-helper 2 Cell Differentiation (GO:0045064),1/5,0.02352761014601,0.138418245758626,0,0,52.9281914893617,198.458522523967,MYB
Regulation Of Macrophage Apoptotic Process (GO:2000109),1/5,0.02352761014601,0.138418245758626,0,0,52.9281914893617,198.458522523967,IRF7
Negative Regulation Of Vitamin Metabolic Process (GO:0046137),1/5,0.02352761014601,0.138418245758626,0,0,52.9281914893617,198.458522523967,GFI1
Positive Regulation Of Toll-Like Receptor 7 Signaling Pathway (GO:0034157),1/5,0.02352761014601,0.138418245758626,0,0,52.9281914893617,198.458522523967,RSAD2
Attachment Of GPI Anchor To Protein (GO:0016255),1/5,0.02352761014601,0.138418245758626,0,0,52.9281914893617,198.458522523967,PGAP1
Mesenchymal Cell Differentiation Involved In Kidney Development (GO:0072161),1/5,0.02352761014601,0.138418245758626,0,0,52.9281914893617,198.458522523967,STAT1
Response To cGMP (GO:0070305),1/5,0.02352761014601,0.138418245758626,0,0,52.9281914893617,198.458522523967,TLR7
Regulation Of Calcidiol 1-Monooxygenase Activity (GO:0060558),1/5,0.02352761014601,0.138418245758626,0,0,52.9281914893617,198.458522523967,GFI1
Blood Circulation (GO:0008015),2/50,0.0235916467130086,0.138418245758626,0,0,8.89650537634409,33.3339831091469,STAT1;MYOF
Positive Regulation Of B Cell Activation (GO:0050871),2/52,0.0253814066741901,0.14365168539549,0,0,8.53978494623656,31.372935831074,CD38;TNFSF13B
Negative Regulation Of Cysteine-Type Endopeptidase Activity (GO:2000117),2/53,0.0262964497190091,0.14365168539549,0,0,8.3719165085389,30.4597224945985,LAMP3;IFI6
Positive Regulation Of Tyrosine Phosphorylation Of STAT Protein (GO:0042531),2/55,0.0281661384295003,0.14365168539549,0,0,8.05518360722256,28.7540636236001,PARP9;IL6ST
Response To Peptide Hormone (GO:0043434),2/55,0.0281661384295003,0.14365168539549,0,0,8.05518360722256,28.7540636236001,IRS1;STAT1
Negative Regulation Of Hematopoietic Progenitor Cell Differentiation (GO:1901533),1/6,0.0281669971363706,0.14365168539549,0,0,42.3404255319149,151.13856507235,MYB
Toll-Like Receptor 3 Signaling Pathway (GO:0034138),1/6,0.0281669971363706,0.14365168539549,0,0,42.3404255319149,151.13856507235,OAS1
Glandular Epithelial Cell Development (GO:0002068),1/6,0.0281669971363706,0.14365168539549,0,0,42.3404255319149,151.13856507235,CDK6
Regulation Of Glial Cell Differentiation (GO:0045685),1/6,0.0281669971363706,0.14365168539549,0,0,42.3404255319149,151.13856507235,TNFRSF21
RIG-I Signaling Pathway (GO:0039529),1/6,0.0281669971363706,0.14365168539549,0,0,42.3404255319149,151.13856507235,OAS3
Type B Pancreatic Cell Development (GO:0003323),1/6,0.0281669971363706,0.14365168539549,0,0,42.3404255319149,151.13856507235,CDK6
Regulation Of Hemoglobin Biosynthetic Process (GO:0046984),1/6,0.0281669971363706,0.14365168539549,0,0,42.3404255319149,151.13856507235,EIF2AK2
Interleukin-9-Mediated Signaling Pathway (GO:0038113),1/6,0.0281669971363706,0.14365168539549,0,0,42.3404255319149,151.13856507235,STAT1
Macrophage Derived Foam Cell Differentiation (GO:0010742),1/6,0.0281669971363706,0.14365168539549,0,0,42.3404255319149,151.13856507235,STAT1
Cellular Response To Interleukin-9 (GO:0071355),1/6,0.0281669971363706,0.14365168539549,0,0,42.3404255319149,151.13856507235,STAT1
Regulation Of Toll-Like Receptor 7 Signaling Pathway (GO:0034155),1/6,0.0281669971363706,0.14365168539549,0,0,42.3404255319149,151.13856507235,RSAD2
Regulation Of MDA-5 Signaling Pathway (GO:0039533),1/6,0.0281669971363706,0.14365168539549,0,0,42.3404255319149,151.13856507235,DDX60
Response To Lead Ion (GO:0010288),1/6,0.0281669971363706,0.14365168539549,0,0,42.3404255319149,151.13856507235,PLSCR1
Positive Regulation Of Programmed Cell Death (GO:0043068),4/245,0.0294295332717009,0.14894488976441,0,0,3.58652136245497,12.6452012778946,GBP5;GBP2;GBP1;IFIT2
Ubiquitin-Dependent Protein Catabolic Process (GO:0006511),5/367,0.0306903266514757,0.149904638826555,0,0,2.99923265807244,10.4487500287138,HERC5;IFI27;MVB12B;TNFSF13B;HERC6
Positive Regulation Of Type II Interferon Production (GO:0032729),2/58,0.0310675388215463,0.149904638826555,0,0,7.62250384024578,26.4622216191549,TLR7;ISG15
Regulation Of Type I Interferon Production (GO:0032479),2/59,0.0320599403367199,0.149904638826555,0,0,7.48839841539332,25.7611987779317,IRF7;XAF1
Regulation Of Chemokine (C-C Motif) Ligand 5 Production (GO:0071649),1/7,0.0327845741023386,0.149904638826555,0,0,35.281914893617,120.58642908645,OAS3
Sulfur Amino Acid Transport (GO:0000101),1/7,0.0327845741023386,0.149904638826555,0,0,35.281914893617,120.58642908645,SLC7A11
Positive Regulation Of Isomerase Activity (GO:0010912),1/7,0.0327845741023386,0.149904638826555,0,0,35.281914893617,120.58642908645,PLSCR1
Foam Cell Differentiation (GO:0090077),1/7,0.0327845741023386,0.149904638826555,0,0,35.281914893617,120.58642908645,STAT1
Negative Regulation Of Monooxygenase Activity (GO:0032769),1/7,0.0327845741023386,0.149904638826555,0,0,35.281914893617,120.58642908645,GFI1
Negative Regulation Of Osteoblast Proliferation (GO:0033689),1/7,0.0327845741023386,0.149904638826555,0,0,35.281914893617,120.58642908645,EIF2AK2
Regulation Of Myeloid Leukocyte Differentiation (GO:0002761),1/7,0.0327845741023386,0.149904638826555,0,0,35.281914893617,120.58642908645,IRF7
Lymphocyte Apoptotic Process (GO:0070227),1/7,0.0327845741023386,0.149904638826555,0,0,35.281914893617,120.58642908645,TNFRSF21
Cellular Modified Amino Acid Biosynthetic Process (GO:0042398),1/7,0.0327845741023386,0.149904638826555,0,0,35.281914893617,120.58642908645,PLSCR1
Plasma Membrane Phospholipid Scrambling (GO:0017121),1/7,0.0327845741023386,0.149904638826555,0,0,35.281914893617,120.58642908645,PLSCR1
Positive Regulation Of T-helper 2 Cell Cytokine Production (GO:2000553),1/7,0.0327845741023386,0.149904638826555,0,0,35.281914893617,120.58642908645,RSAD2
Negative Regulation Of Cell Population Proliferation (GO:0008285),5/379,0.0345362598574605,0.153933125113652,0,0,2.90121806298277,9.76476162987294,IFITM1;CDK6;EIF2AK2;IFI35;IFIT3
Negative Regulation Of Programmed Cell Death (GO:0043069),5/381,0.0352051038056153,0.153933125113652,0,0,2.88549054373522,9.65647938891484,IFI6;CD38;SLC7A11;IL6ST;IFIT3
G1/S Transition Of Mitotic Cell Cycle (GO:0000082),2/63,0.0361521995081931,0.153933125113652,0,0,6.99594570773841,23.2266620968529,CDK6;GFI1
Cellular Response To Virus (GO:0098586),2/64,0.0372052475375679,0.153933125113652,0,0,6.88276101283385,22.6532689345462,OAS1;IFI6
Type B Pancreatic Cell Differentiation (GO:0003309),1/8,0.037380442146754,0.153933125113652,0,0,30.2401215805471,99.3874148810262,CDK6
Regulation Of Helicase Activity (GO:0051095),1/8,0.037380442146754,0.153933125113652,0,0,30.2401215805471,99.3874148810262,IFIT1
Regulation Of Interleukin-18 Production (GO:0032661),1/8,0.037380442146754,0.153933125113652,0,0,30.2401215805471,99.3874148810262,GBP5
Intestinal Epithelial Cell Differentiation (GO:0060575),1/8,0.037380442146754,0.153933125113652,0,0,30.2401215805471,99.3874148810262,IL6ST
Regulation Of Pattern Recognition Receptor Signaling Pathway (GO:0062207),1/8,0.037380442146754,0.153933125113652,0,0,30.2401215805471,99.3874148810262,GFI1
Proteasome Assembly (GO:0043248),1/8,0.037380442146754,0.153933125113652,0,0,30.2401215805471,99.3874148810262,NT5C3A
Protein poly-ADP-ribosylation (GO:0070212),1/8,0.037380442146754,0.153933125113652,0,0,30.2401215805471,99.3874148810262,PARP9
Pyrimidine-Containing Compound Metabolic Process (GO:0072527),1/8,0.037380442146754,0.153933125113652,0,0,30.2401215805471,99.3874148810262,NT5C3A
Modification-Dependent Macromolecule Catabolic Process (GO:0043632),1/8,0.037380442146754,0.153933125113652,0,0,30.2401215805471,99.3874148810262,ISG15
Positive Regulation Of Adaptive Immune Response (GO:0002821),1/8,0.037380442146754,0.153933125113652,0,0,30.2401215805471,99.3874148810262,IL6ST
Positive Regulation Of Chromatin Binding (GO:0035563),1/8,0.037380442146754,0.153933125113652,0,0,30.2401215805471,99.3874148810262,PARP9
Positive Regulation Of Fatty Acid Beta-Oxidation (GO:0032000),1/8,0.037380442146754,0.153933125113652,0,0,30.2401215805471,99.3874148810262,IRS1
Regulation Of Tyrosine Phosphorylation Of STAT Protein (GO:0042509),2/65,0.0382700203044697,0.156623601616441,0,0,6.7731694828469,22.1014511025041,PARP9;IL6ST
I-kappaB Phosphorylation (GO:0007252),1/9,0.0419547020061368,0.163623337823934,0,0,26.4587765957447,83.9051401021397,TLR7
Positive Regulation Of Mesenchymal Cell Proliferation (GO:0002053),1/9,0.0419547020061368,0.163623337823934,0,0,26.4587765957447,83.9051401021397,STAT1
NAD Biosynthesis Via Nicotinamide Riboside Salvage Pathway (GO:0034356),1/9,0.0419547020061368,0.163623337823934,0,0,26.4587765957447,83.9051401021397,PARP9
Type II Interferon-Mediated Signaling Pathway (GO:0060333),1/9,0.0419547020061368,0.163623337823934,0,0,26.4587765957447,83.9051401021397,STAT1
Regulation Of Mast Cell Activation (GO:0033003),1/9,0.0419547020061368,0.163623337823934,0,0,26.4587765957447,83.9051401021397,PLSCR1
Nucleoside Metabolic Process (GO:0009116),1/9,0.0419547020061368,0.163623337823934,0,0,26.4587765957447,83.9051401021397,NT5C3A
Cell Differentiation Involved In Metanephros Development (GO:0072202),1/9,0.0419547020061368,0.163623337823934,0,0,26.4587765957447,83.9051401021397,STAT1
Regulation Of ER To Golgi Vesicle-Mediated Transport (GO:0060628),1/9,0.0419547020061368,0.163623337823934,0,0,26.4587765957447,83.9051401021397,PGAP1
Negative Regulation Of Cellular Process (GO:0048523),6/537,0.0427652534225842,0.164890064287964,0,0,2.45972195772234,7.75311578398258,IFITM1;CDK6;EIF2AK2;IFI35;IFIT3;TNFRSF21
Negative Regulation Of Protein Binding (GO:0032091),2/71,0.0448975208095009,0.164890064287964,0,0,6.18232819074334,19.1860685393763,IFIT1;IFIT2
Negative Regulation Of Cellular Response To Growth Factor Stimulus (GO:0090288),2/71,0.0448975208095009,0.164890064287964,0,0,6.18232819074334,19.1860685393763,GPR155;SKIL
Regulation Of Cytokine Production (GO:0001817),3/167,0.0453269139820205,0.164890064287964,0,0,3.9251723223754,12.1439112492901,IRF7;EIF2AK2;ISG15
Plasma Membrane Organization (GO:0007009),2/72,0.0460407090706988,0.164890064287964,0,0,6.0937019969278,18.7578119962089,PLSCR1;MYOF
Regulation Of Chromatin Binding (GO:0035561),1/10,0.0465074540299385,0.164890064287964,0,0,23.5177304964539,72.1557526145054,PARP9
Surfactant Homeostasis (GO:0043129),1/10,0.0465074540299385,0.164890064287964,0,0,23.5177304964539,72.1557526145054,OAS1
Heparan Sulfate Proteoglycan Biosynthetic Process, Enzymatic Modification (GO:0015015),1/10,0.0465074540299385,0.164890064287964,0,0,23.5177304964539,72.1557526145054,HS3ST1
Negative Regulation Of Steroid Biosynthetic Process (GO:0010894),1/10,0.0465074540299385,0.164890064287964,0,0,23.5177304964539,72.1557526145054,GFI1
Regulation Of Mitochondrial Depolarization (GO:0051900),1/10,0.0465074540299385,0.164890064287964,0,0,23.5177304964539,72.1557526145054,IFI6
Insulin-Like Growth Factor Receptor Signaling Pathway (GO:0048009),1/10,0.0465074540299385,0.164890064287964,0,0,23.5177304964539,72.1557526145054,IRS1
Positive Regulation Of Toll-Like Receptor 4 Signaling Pathway (GO:0034145),1/10,0.0465074540299385,0.164890064287964,0,0,23.5177304964539,72.1557526145054,IFI35
Metanephric Mesenchyme Development (GO:0072075),1/10,0.0465074540299385,0.164890064287964,0,0,23.5177304964539,72.1557526145054,STAT1
Regulation Of Toll-Like Receptor 9 Signaling Pathway (GO:0034163),1/10,0.0465074540299385,0.164890064287964,0,0,23.5177304964539,72.1557526145054,RSAD2
Negative Regulation Of B Cell Proliferation (GO:0030889),1/10,0.0465074540299385,0.164890064287964,0,0,23.5177304964539,72.1557526145054,TNFRSF21
Regulation Of T-helper 2 Cell Cytokine Production (GO:2000551),1/10,0.0465074540299385,0.164890064287964,0,0,23.5177304964539,72.1557526145054,RSAD2
Endosomal Vesicle Fusion (GO:0034058),1/10,0.0465074540299385,0.164890064287964,0,0,23.5177304964539,72.1557526145054,SAMD9
Positive Regulation Of Nucleic Acid-Templated Transcription (GO:1903508),6/557,0.0495070456966201,0.172646546766248,0,0,2.3679928220396,7.11733461395615,STAT1;MYB;IRF7;CD38;BRCA2;PARP9
Regulation Of BMP Signaling Pathway (GO:0030510),2/75,0.0495339216944764,0.172646546766248,0,0,5.84239210487553,17.5569582434549,GPR155;SKIL
Negative Regulation Of Leukocyte Apoptotic Process (GO:2000107),1/11,0.0510387981390417,0.172646546766248,0,0,21.1648936170213,62.9691393493665,IRF7
Positive Regulation Of Platelet Aggregation (GO:1901731),1/11,0.0510387981390417,0.172646546766248,0,0,21.1648936170213,62.9691393493665,IL6ST
Histone H2A Ubiquitination (GO:0033522),1/11,0.0510387981390417,0.172646546766248,0,0,21.1648936170213,62.9691393493665,BRCA2
Regulation Of Mesenchymal Cell Proliferation (GO:0010464),1/11,0.0510387981390417,0.172646546766248,0,0,21.1648936170213,62.9691393493665,STAT1
Macrophage Activation Involved In Immune Response (GO:0002281),1/11,0.0510387981390417,0.172646546766248,0,0,21.1648936170213,62.9691393493665,IFI35
Regulation Of Type II Interferon-Mediated Signaling Pathway (GO:0060334),1/11,0.0510387981390417,0.172646546766248,0,0,21.1648936170213,62.9691393493665,PARP9
Regulation Of Cell Cycle Checkpoint (GO:1901976),1/11,0.0510387981390417,0.172646546766248,0,0,21.1648936170213,62.9691393493665,BRCA2
Cell Morphogenesis Involved In Neuron Differentiation (GO:0048667),2/77,0.0519145318907259,0.173835023452279,0,0,5.68602150537634,16.8201416464628,CFAP418;BTBD3
Regulation Of T Cell Proliferation (GO:0042129),2/77,0.0519145318907259,0.173835023452279,0,0,5.68602150537634,16.8201416464628,IL6ST;TNFRSF21
Negative Regulation Of Cytokine Production (GO:0001818),3/178,0.0529696811159098,0.176476877285669,0,0,3.67639751552795,10.8013867198311,XAF1;GBP1;TNFRSF21
Regulation Of Chromosome Separation (GO:1905818),1/12,0.0555488338237399,0.1779172793485,0,0,19.2398452611219,55.6126333613154,PLSCR1
Positive Regulation Of Insulin Receptor Signaling Pathway (GO:0046628),1/12,0.0555488338237399,0.1779172793485,0,0,19.2398452611219,55.6126333613154,IRS1
Regulation Of Hematopoietic Stem Cell Differentiation (GO:1902036),1/12,0.0555488338237399,0.1779172793485,0,0,19.2398452611219,55.6126333613154,EIF2AK2
Regulation Of Interleukin-5 Production (GO:0032674),1/12,0.0555488338237399,0.1779172793485,0,0,19.2398452611219,55.6126333613154,TNFRSF21
Histone Monoubiquitination (GO:0010390),1/12,0.0555488338237399,0.1779172793485,0,0,19.2398452611219,55.6126333613154,BRCA2
Negative Regulation Of Substrate Adhesion-Dependent Cell Spreading (GO:1900025),1/12,0.0555488338237399,0.1779172793485,0,0,19.2398452611219,55.6126333613154,GBP1
Negative Regulation Of Alcohol Biosynthetic Process (GO:1902931),1/12,0.0555488338237399,0.1779172793485,0,0,19.2398452611219,55.6126333613154,GFI1
Positive Regulation Of Fatty Acid Oxidation (GO:0046321),1/12,0.0555488338237399,0.1779172793485,0,0,19.2398452611219,55.6126333613154,IRS1
Protein Ubiquitination (GO:0016567),5/434,0.0558958607717927,0.178168056210089,0,0,2.52214452214452,7.2745330404718,HERC5;ISG15;BRCA2;TNFSF13B;HERC6
Cellular Response To Interleukin-1 (GO:0071347),2/81,0.0567957014903864,0.180170096115436,0,0,5.39703280250442,15.4802802275116,GBP2;GBP1
Positive Regulation Of Glycogen Biosynthetic Process (GO:0045725),1/13,0.060037660145892,0.182591599434525,0,0,17.6356382978723,49.6052279114411,IRS1
Regulation Of Fatty Acid Beta-Oxidation (GO:0031998),1/13,0.060037660145892,0.182591599434525,0,0,17.6356382978723,49.6052279114411,IRS1
Heparan Sulfate Proteoglycan Metabolic Process (GO:0030201),1/13,0.060037660145892,0.182591599434525,0,0,17.6356382978723,49.6052279114411,HS3ST1
Acute-Phase Response (GO:0006953),1/13,0.060037660145892,0.182591599434525,0,0,17.6356382978723,49.6052279114411,PLSCR1
Negative Regulation Of Translational Initiation (GO:0045947),1/13,0.060037660145892,0.182591599434525,0,0,17.6356382978723,49.6052279114411,EIF2AK2
Interleukin-6-Mediated Signaling Pathway (GO:0070102),1/13,0.060037660145892,0.182591599434525,0,0,17.6356382978723,49.6052279114411,IL6ST
Positive Regulation Of Type 2 Immune Response (GO:0002830),1/13,0.060037660145892,0.182591599434525,0,0,17.6356382978723,49.6052279114411,RSAD2
Positive Regulation Of Cellular Response To Insulin Stimulus (GO:1900078),1/13,0.060037660145892,0.182591599434525,0,0,17.6356382978723,49.6052279114411,IRS1
Positive Regulation Of Chromosome Separation (GO:1905820),1/13,0.060037660145892,0.182591599434525,0,0,17.6356382978723,49.6052279114411,PLSCR1
Regulation Of Cysteine-Type Endopeptidase Activity Involved In Apoptotic Process (GO:0043281),2/84,0.0605577907014895,0.182765231221142,0,0,5.19879360083923,14.5782342558469,LAMP3;IFI6
Response To Interleukin-1 (GO:0070555),2/85,0.0618304768429492,0.182765231221142,0,0,5.13589843243944,14.2950485255533,GBP2;GBP1
Defense Response To Gram-positive Bacterium (GO:0050830),2/85,0.0618304768429492,0.182765231221142,0,0,5.13589843243944,14.2950485255533,GBP2;GBP4
Negative Regulation Of Binding (GO:0051100),2/86,0.0631123000545205,0.182765231221142,0,0,5.07450076804916,14.0200316665264,IFIT1;IFIT2
Glucose Homeostasis (GO:0042593),2/87,0.0644031469349444,0.182765231221142,0,0,5.01454775458571,13.7528624747968,OAS1;IRS1
Regulation Of Type II Interferon Production (GO:0032649),2/87,0.0644031469349444,0.182765231221142,0,0,5.01454775458571,13.7528624747968,TLR7;ISG15
Positive Regulation Of Glycogen Metabolic Process (GO:0070875),1/14,0.064505375725109,0.182765231221142,0,0,16.278232405892,44.6187443178727,IRS1
Establishment Of Protein Localization To Chromosome (GO:0070199),1/14,0.064505375725109,0.182765231221142,0,0,16.278232405892,44.6187443178727,BRCA2
L-glutamate Transmembrane Transport (GO:0015813),1/14,0.064505375725109,0.182765231221142,0,0,16.278232405892,44.6187443178727,SLC7A11
Vascular Endothelial Growth Factor Signaling Pathway (GO:0038084),1/14,0.064505375725109,0.182765231221142,0,0,16.278232405892,44.6187443178727,GAB1
Regulation Of Leukocyte Activation (GO:0002694),1/14,0.064505375725109,0.182765231221142,0,0,16.278232405892,44.6187443178727,PLSCR1
Histone H2A Monoubiquitination (GO:0035518),1/14,0.064505375725109,0.182765231221142,0,0,16.278232405892,44.6187443178727,BRCA2
Protein Localization To Vacuole (GO:0072665),1/14,0.064505375725109,0.182765231221142,0,0,16.278232405892,44.6187443178727,GBP1
Cellular Response To Exogenous dsRNA (GO:0071360),1/14,0.064505375725109,0.182765231221142,0,0,16.278232405892,44.6187443178727,IFIT1
Photoreceptor Cell Development (GO:0042461),1/14,0.064505375725109,0.182765231221142,0,0,16.278232405892,44.6187443178727,CFAP418
Positive Regulation Of Acute Inflammatory Response (GO:0002675),1/14,0.064505375725109,0.182765231221142,0,0,16.278232405892,44.6187443178727,IL6ST
Positive Regulation Of Glucose Metabolic Process (GO:0010907),1/15,0.0689520787299209,0.18890590164437,0,0,15.1147416413374,40.4220114682192,IRS1
Stem Cell Development (GO:0048864),1/15,0.0689520787299209,0.18890590164437,0,0,15.1147416413374,40.4220114682192,TAPT1
L-glutamate Import (GO:0051938),1/15,0.0689520787299209,0.18890590164437,0,0,15.1147416413374,40.4220114682192,SLC7A11
Negative Regulation Of Phagocytosis (GO:0050765),1/15,0.0689520787299209,0.18890590164437,0,0,15.1147416413374,40.4220114682192,PLSCR1
Regulation Of Interleukin-13 Production (GO:0032656),1/15,0.0689520787299209,0.18890590164437,0,0,15.1147416413374,40.4220114682192,TNFRSF21
Alpha-Beta T Cell Activation (GO:0046631),1/15,0.0689520787299209,0.18890590164437,0,0,15.1147416413374,40.4220114682192,RSAD2
Astrocyte Development (GO:0014002),1/15,0.0689520787299209,0.18890590164437,0,0,15.1147416413374,40.4220114682192,CDK6
Protein Localization To Chromosome, Telomeric Region (GO:0070198),1/15,0.0689520787299209,0.18890590164437,0,0,15.1147416413374,40.4220114682192,BRCA2
Negative Regulation Of Transcription By RNA Polymerase II (GO:0000122),7/763,0.0709396712682345,0.190037209997651,0,0,2.01483585858586,5.33110550318306,IFI27;SATB1;STAT1;GFI1;MYB;IRF7;PARP9
Positive Regulation Of Homotypic Cell-Cell Adhesion (GO:0034112),1/16,0.0733778669070871,0.190037209997651,0,0,14.1063829787234,36.8477474964079,IL6ST
Establishment Of Protein Localization To Endoplasmic Reticulum (GO:0072599),1/16,0.0733778669070871,0.190037209997651,0,0,14.1063829787234,36.8477474964079,MAN1A1
Negative Regulation Of Interleukin-10 Production (GO:0032693),1/16,0.0733778669070871,0.190037209997651,0,0,14.1063829787234,36.8477474964079,TNFRSF21
Positive Regulation Of Muscle Hypertrophy (GO:0014742),1/16,0.0733778669070871,0.190037209997651,0,0,14.1063829787234,36.8477474964079,IL6ST
Regulation Of Osteoblast Proliferation (GO:0033688),1/16,0.0733778669070871,0.190037209997651,0,0,14.1063829787234,36.8477474964079,EIF2AK2
Protein Alpha-1,2-Demannosylation (GO:0036508),1/16,0.0733778669070871,0.190037209997651,0,0,14.1063829787234,36.8477474964079,MAN1A1
Cell Surface Toll-Like Receptor Signaling Pathway (GO:0140895),1/16,0.0733778669070871,0.190037209997651,0,0,14.1063829787234,36.8477474964079,OAS1
Regulation Of Response To Cytokine Stimulus (GO:0060759),1/16,0.0733778669070871,0.190037209997651,0,0,14.1063829787234,36.8477474964079,PARP9
Protein Localization To Mitochondrion (GO:0070585),1/16,0.0733778669070871,0.190037209997651,0,0,14.1063829787234,36.8477474964079,ISG15
Regulation Of Secretion (GO:0051046),1/16,0.0733778669070871,0.190037209997651,0,0,14.1063829787234,36.8477474964079,OAS2
Regulation Of Stem Cell Proliferation (GO:0072091),1/16,0.0733778669070871,0.190037209997651,0,0,14.1063829787234,36.8477474964079,EIF2AK2
Cellular Response To Fatty Acid (GO:0071398),1/16,0.0733778669070871,0.190037209997651,0,0,14.1063829787234,36.8477474964079,IRS1
Negative Regulation Of ATP-dependent Activity (GO:0032780),1/16,0.0733778669070871,0.190037209997651,0,0,14.1063829787234,36.8477474964079,IFIT1
Negative Regulation Of Insulin Secretion (GO:0046676),1/17,0.0777828375206224,0.193867540883965,0,0,13.2240691489362,33.7720836203226,IRS1
Toll-Like Receptor 4 Signaling Pathway (GO:0034142),1/17,0.0777828375206224,0.193867540883965,0,0,13.2240691489362,33.7720836203226,OAS1
NAD Biosynthetic Process (GO:0009435),1/17,0.0777828375206224,0.193867540883965,0,0,13.2240691489362,33.7720836203226,PARP9
Cellular Response To dsRNA (GO:0071359),1/17,0.0777828375206224,0.193867540883965,0,0,13.2240691489362,33.7720836203226,IFIT1
Myeloid Cell Activation Involved In Immune Response (GO:0002275),1/17,0.0777828375206224,0.193867540883965,0,0,13.2240691489362,33.7720836203226,IFI35
Positive Regulation Of Cardiac Muscle Hypertrophy (GO:0010613),1/17,0.0777828375206224,0.193867540883965,0,0,13.2240691489362,33.7720836203226,IL6ST
Positive Regulation Of Cartilage Development (GO:0061036),1/17,0.0777828375206224,0.193867540883965,0,0,13.2240691489362,33.7720836203226,TAPT1
Regulation Of Cartilage Development (GO:0061035),1/17,0.0777828375206224,0.193867540883965,0,0,13.2240691489362,33.7720836203226,TAPT1
Negative Regulation Of Cellular Senescence (GO:2000773),1/17,0.0777828375206224,0.193867540883965,0,0,13.2240691489362,33.7720836203226,CDK6
Regulation Of Defense Response (GO:0031347),2/97,0.0777835718667187,0.193867540883965,0,0,4.48443689869836,11.4524671911645,HERC5;USP18
Negative Regulation Of Apoptotic Process (GO:0043066),5/482,0.0796249425489302,0.193867540883965,0,0,2.26275331935709,5.72573409982182,LAMP3;IFI6;CD38;IL6ST;IFIT3
Cellular Response To Insulin Stimulus (GO:0032869),2/99,0.0805570248539892,0.193867540883965,0,0,4.39153087240882,11.0613438795142,IRS1;GAB1
Regulation Of Defense Response To Virus (GO:0050688),1/18,0.0821670874636413,0.193867540883965,0,0,12.4455569461827,31.1014524453431,HERC5
Positive Regulation Of Neuroblast Proliferation (GO:0002052),1/18,0.0821670874636413,0.193867540883965,0,0,12.4455569461827,31.1014524453431,HAPLN3
Negative Regulation Of Peptide Hormone Secretion (GO:0090278),1/18,0.0821670874636413,0.193867540883965,0,0,12.4455569461827,31.1014524453431,IRS1
T-helper Cell Differentiation (GO:0042093),1/18,0.0821670874636413,0.193867540883965,0,0,12.4455569461827,31.1014524453431,MYB
Negative Regulation Of Viral Entry Into Host Cell (GO:0046597),1/18,0.0821670874636413,0.193867540883965,0,0,12.4455569461827,31.1014524453431,IFITM1
Positive Regulation Of Stress-Activated Protein Kinase Signaling Cascade (GO:0070304),1/18,0.0821670874636413,0.193867540883965,0,0,12.4455569461827,31.1014524453431,EIF2AK2
Neural Crest Cell Differentiation (GO:0014033),1/18,0.0821670874636413,0.193867540883965,0,0,12.4455569461827,31.1014524453431,TAPT1
Regulation Of Oligodendrocyte Differentiation (GO:0048713),1/18,0.0821670874636413,0.193867540883965,0,0,12.4455569461827,31.1014524453431,TNFRSF21
Positive Regulation Of NLRP3 Inflammasome Complex Assembly (GO:1900227),1/18,0.0821670874636413,0.193867540883965,0,0,12.4455569461827,31.1014524453431,GBP5
Regulation Of DNA Damage Checkpoint (GO:2000001),1/18,0.0821670874636413,0.193867540883965,0,0,12.4455569461827,31.1014524453431,BRCA2
Negative Regulation Of T Cell Receptor Signaling Pathway (GO:0050860),1/18,0.0821670874636413,0.193867540883965,0,0,12.4455569461827,31.1014524453431,GBP1
Positive Regulation Of Cytokine Production Involved In Inflammatory Response (GO:1900017),1/18,0.0821670874636413,0.193867540883965,0,0,12.4455569461827,31.1014524453431,GBP5
Regulation Of Cell Cycle G2/M Phase Transition (GO:1902749),1/18,0.0821670874636413,0.193867540883965,0,0,12.4455569461827,31.1014524453431,CDK6
N-glycan Processing (GO:0006491),1/19,0.0865307131072755,0.199200912465707,0,0,11.7535460992908,28.7639346053616,MAN1A1
Regulation Of Megakaryocyte Differentiation (GO:0045652),1/19,0.0865307131072755,0.199200912465707,0,0,11.7535460992908,28.7639346053616,MYB
Neuron Apoptotic Process (GO:0051402),1/19,0.0865307131072755,0.199200912465707,0,0,11.7535460992908,28.7639346053616,TNFRSF21
Regulation Of Transcription Involved In G1/S Transition Of Mitotic Cell Cycle (GO:0000083),1/19,0.0865307131072755,0.199200912465707,0,0,11.7535460992908,28.7639346053616,GFI1
Release Of Cytochrome C From Mitochondria (GO:0001836),1/19,0.0865307131072755,0.199200912465707,0,0,11.7535460992908,28.7639346053616,IFI6
Response To Fatty Acid (GO:0070542),1/19,0.0865307131072755,0.199200912465707,0,0,11.7535460992908,28.7639346053616,IRS1
Regulation Of Acute Inflammatory Response (GO:0002673),1/19,0.0865307131072755,0.199200912465707,0,0,11.7535460992908,28.7639346053616,IL6ST
Positive Regulation Of Lipid Catabolic Process (GO:0050996),1/20,0.0908738104379916,0.204235038374198,0,0,11.1343784994401,26.7033954953546,IRS1
Negative Regulation Of Protein Localization To Cell Periphery (GO:1904376),1/20,0.0908738104379916,0.204235038374198,0,0,11.1343784994401,26.7033954953546,GBP1
Negative Regulation Of Protein Localization To Plasma Membrane (GO:1903077),1/20,0.0908738104379916,0.204235038374198,0,0,11.1343784994401,26.7033954953546,GBP1
Negative Regulation Of Viral Life Cycle (GO:1903901),1/20,0.0908738104379916,0.204235038374198,0,0,11.1343784994401,26.7033954953546,IFITM1
Regulation Of Protein Localization To Cell Periphery (GO:1904375),1/20,0.0908738104379916,0.204235038374198,0,0,11.1343784994401,26.7033954953546,GBP1
Phosphatidylserine Metabolic Process (GO:0006658),1/20,0.0908738104379916,0.204235038374198,0,0,11.1343784994401,26.7033954953546,PLSCR1
Negative Regulation Of B Cell Activation (GO:0050869),1/20,0.0908738104379916,0.204235038374198,0,0,11.1343784994401,26.7033954953546,TNFRSF21
Cellular Response To Lipid (GO:0071396),3/228,0.0946961713537448,0.208301197765594,0,0,2.85217391304348,6.72280696080295,IRS1;GFI1;GBP2
Negative Regulation Of Interleukin-2 Production (GO:0032703),1/21,0.0951964749969455,0.208301197765594,0,0,10.5771276595745,24.8754196182274,GBP1
Aminoglycan Biosynthetic Process (GO:0006023),1/21,0.0951964749969455,0.208301197765594,0,0,10.5771276595745,24.8754196182274,HS3ST1
Regulation Of Neurotransmitter Transport (GO:0051588),1/21,0.0951964749969455,0.208301197765594,0,0,10.5771276595745,24.8754196182274,MYOF
Plasma Membrane Repair (GO:0001778),1/21,0.0951964749969455,0.208301197765594,0,0,10.5771276595745,24.8754196182274,MYOF
Modulation By Host Of Viral Genome Replication (GO:0044827),1/21,0.0951964749969455,0.208301197765594,0,0,10.5771276595745,24.8754196182274,IFI27
Positive Regulation Of G2/M Transition Of Mitotic Cell Cycle (GO:0010971),1/21,0.0951964749969455,0.208301197765594,0,0,10.5771276595745,24.8754196182274,TNFSF13B
Positive Regulation Of T Cell Cytokine Production (GO:0002726),1/21,0.0951964749969455,0.208301197765594,0,0,10.5771276595745,24.8754196182274,RSAD2
Negative Regulation Of Transmembrane Receptor Protein Serine/Threonine Kinase Signaling Pathway (GO:0090101),2/111,0.0978102479272063,0.21279905039259,0,0,3.90569201933511,9.07966348420853,SKIL;GPR155
Negative Regulation Of Extrinsic Apoptotic Signaling Pathway In Absence Of Ligand (GO:2001240),1/22,0.0994988018426892,0.21279905039259,0,0,10.0729483282675,23.2444330349282,IFI6
Negative Regulation Of Signal Transduction In Absence Of Ligand (GO:1901099),1/22,0.0994988018426892,0.21279905039259,0,0,10.0729483282675,23.2444330349282,IFI6
Postreplication Repair (GO:0006301),1/22,0.0994988018426892,0.21279905039259,0,0,10.0729483282675,23.2444330349282,TNFSF13B
Regulation Of Protein Export From Nucleus (GO:0046825),1/22,0.0994988018426892,0.21279905039259,0,0,10.0729483282675,23.2444330349282,IFI27
Modulation By Host Of Viral Process (GO:0044788),1/22,0.0994988018426892,0.21279905039259,0,0,10.0729483282675,23.2444330349282,IFI27
Positive Regulation Of Cilium Assembly (GO:0045724),1/22,0.0994988018426892,0.21279905039259,0,0,10.0729483282675,23.2444330349282,TAPT1
Glial Cell Development (GO:0021782),1/23,0.103780885658125,0.217055921739232,0,0,9.61460348162476,21.7816291226009,CDK6
Translesion Synthesis (GO:0019985),1/23,0.103780885658125,0.217055921739232,0,0,9.61460348162476,21.7816291226009,TNFSF13B
Heparan Sulfate Proteoglycan Biosynthetic Process (GO:0015012),1/23,0.103780885658125,0.217055921739232,0,0,9.61460348162476,21.7816291226009,HS3ST1
Protein Targeting To ER (GO:0045047),1/23,0.103780885658125,0.217055921739232,0,0,9.61460348162476,21.7816291226009,MAN1A1
Cellular Response To Interleukin-6 (GO:0071354),1/23,0.103780885658125,0.217055921739232,0,0,9.61460348162476,21.7816291226009,IL6ST
Regulation Of Toll-Like Receptor 4 Signaling Pathway (GO:0034143),1/23,0.103780885658125,0.217055921739232,0,0,9.61460348162476,21.7816291226009,IFI35
Regulation Of Cardiac Muscle Hypertrophy (GO:0010611),1/23,0.103780885658125,0.217055921739232,0,0,9.61460348162476,21.7816291226009,IL6ST
Regulation Of Inflammatory Response (GO:0050727),3/240,0.106251903743228,0.220961472614614,0,0,2.70610897083104,6.06694085680373,TLR7;IFI35;USP18
Cellular Response To Molecule Of Bacterial Origin (GO:0071219),2/117,0.106795682773765,0.220961472614614,0,0,3.70079476390837,8.27807753187076,GFI1;GBP2
Regulation Of Neuroblast Proliferation (GO:1902692),1/24,0.108042820661995,0.220961472614614,0,0,9.19611470860315,20.4634486561944,HAPLN3
Positive Regulation Of Vascular Endothelial Growth Factor Production (GO:0010575),1/24,0.108042820661995,0.220961472614614,0,0,9.19611470860315,20.4634486561944,IL6ST
Regulation Of Viral Life Cycle (GO:1903900),1/24,0.108042820661995,0.220961472614614,0,0,9.19611470860315,20.4634486561944,LAMP3
Positive Regulation Of Cell Cycle G2/M Phase Transition (GO:1902751),1/24,0.108042820661995,0.220961472614614,0,0,9.19611470860315,20.4634486561944,TNFSF13B
Negative Regulation Of Antigen Receptor-Mediated Signaling Pathway (GO:0050858),1/24,0.108042820661995,0.220961472614614,0,0,9.19611470860315,20.4634486561944,GBP1
Regulation Of Protein Binding (GO:0043393),2/118,0.108314447360105,0.220961472614614,0,0,3.66870596959585,8.15449414553198,IFIT1;IFIT2
Positive Regulation Of Glucose Import (GO:0046326),1/25,0.11228470064332,0.224231194356992,0,0,8.8125,19.2704494051748,IRS1
Regulation Of Glycogen Biosynthetic Process (GO:0005979),1/25,0.11228470064332,0.224231194356992,0,0,8.8125,19.2704494051748,IRS1
Negative Regulation Of Protein Localization To Membrane (GO:1905476),1/25,0.11228470064332,0.224231194356992,0,0,8.8125,19.2704494051748,GBP1
Negative Regulation Of Protein Transport (GO:0051224),1/25,0.11228470064332,0.224231194356992,0,0,8.8125,19.2704494051748,RSAD2
Negative Regulation Of Proteolysis Involved In Protein Catabolic Process (GO:1903051),1/25,0.11228470064332,0.224231194356992,0,0,8.8125,19.2704494051748,LAMP3
Regulation Of Myelination (GO:0031641),1/25,0.11228470064332,0.224231194356992,0,0,8.8125,19.2704494051748,TNFRSF21
Regulation Of Platelet Aggregation (GO:0090330),1/25,0.11228470064332,0.224231194356992,0,0,8.8125,19.2704494051748,IL6ST
Negative Regulation Of DNA-templated Transcription (GO:0045892),8/1025,0.113929555342557,0.226521666797561,0,0,1.70779507001661,3.70962968308578,IFI27;SATB1;STAT1;GFI1;MYB;IRF7;CD38;PARP9
Regulation Of Cell Motility (GO:2000145),2/123,0.115993760936779,0.226521666797561,0,0,3.51621789744957,7.57470296101317,CDK6;SGK3
Negative Regulation Of Insulin Receptor Signaling Pathway (GO:0046627),1/26,0.116506618971295,0.226521666797561,0,0,8.45957446808511,18.1864540360148,IRS1
L-amino Acid Transport (GO:0015807),1/26,0.116506618971295,0.226521666797561,0,0,8.45957446808511,18.1864540360148,SLC7A11
Positive Regulation Of Phosphatidylinositol 3-Kinase Activity (GO:0043552),1/26,0.116506618971295,0.226521666797561,0,0,8.45957446808511,18.1864540360148,IRS1
Acute Inflammatory Response (GO:0002526),1/26,0.116506618971295,0.226521666797561,0,0,8.45957446808511,18.1864540360148,PLSCR1
Regulation Of Myeloid Cell Differentiation (GO:0045637),1/26,0.116506618971295,0.226521666797561,0,0,8.45957446808511,18.1864540360148,CDK6
Regulation Of Vascular Endothelial Growth Factor Production (GO:0010574),1/26,0.116506618971295,0.226521666797561,0,0,8.45957446808511,18.1864540360148,IL6ST
Positive Regulation Of Erythrocyte Differentiation (GO:0045648),1/26,0.116506618971295,0.226521666797561,0,0,8.45957446808511,18.1864540360148,STAT1
Cellular Response To Lipopolysaccharide (GO:0071222),2/124,0.117546115363813,0.227874486801777,0,0,3.48722016569716,7.46587526822685,GFI1;GBP2
Regulation Of Apoptotic Process (GO:0042981),6/705,0.118883829919969,0.228005262874092,0,0,1.85234122582823,3.94476158579088,STAT1;IFI6;CD38;IL6ST;IFIT3;IFIT2
Positive Regulation Of Immune System Process (GO:0002684),1/27,0.120708668580402,0.228005262874092,0,0,8.13379705400982,17.1978998646553,RSAD2
DNA Synthesis Involved In DNA Repair (GO:0000731),1/27,0.120708668580402,0.228005262874092,0,0,8.13379705400982,17.1978998646553,TNFSF13B
GPI Anchor Metabolic Process (GO:0006505),1/27,0.120708668580402,0.228005262874092,0,0,8.13379705400982,17.1978998646553,PGAP1
Regulation Of Extrinsic Apoptotic Signaling Pathway In Absence Of Ligand (GO:2001239),1/27,0.120708668580402,0.228005262874092,0,0,8.13379705400982,17.1978998646553,IFI6
Myeloid Cell Development (GO:0061515),1/27,0.120708668580402,0.228005262874092,0,0,8.13379705400982,17.1978998646553,MYB
Negative Regulation Of NIK/NF-kappaB Signaling (GO:1901223),1/27,0.120708668580402,0.228005262874092,0,0,8.13379705400982,17.1978998646553,IFI35
Positive Regulation Of Cytosolic Calcium Ion Concentration Involved In Phospholipase C-activating G Protein-Coupled Signaling Pathway (GO:0051482),1/27,0.120708668580402,0.228005262874092,0,0,8.13379705400982,17.1978998646553,LPAR6
Negative Regulation Of Cellular Response To Insulin Stimulus (GO:1900077),1/27,0.120708668580402,0.228005262874092,0,0,8.13379705400982,17.1978998646553,IRS1
Regulation Of Response To External Stimulus (GO:0032101),2/127,0.122234633076874,0.230231709460135,0,0,3.40301075268817,7.15249176044108,HERC5;USP18
Regulation Of Glucose Metabolic Process (GO:0010906),1/28,0.12489094195154,0.231292442776175,0,0,7.83215130023641,16.2933370301504,IRS1
Glycosaminoglycan Metabolic Process (GO:0030203),1/28,0.12489094195154,0.231292442776175,0,0,7.83215130023641,16.2933370301504,HS3ST1
Regulation Of Protein Localization To Membrane (GO:1905475),1/28,0.12489094195154,0.231292442776175,0,0,7.83215130023641,16.2933370301504,GBP1
Protein Localization To Golgi Apparatus (GO:0034067),1/28,0.12489094195154,0.231292442776175,0,0,7.83215130023641,16.2933370301504,GBP5
Pyroptosis (GO:0070269),1/28,0.12489094195154,0.231292442776175,0,0,7.83215130023641,16.2933370301504,IFI27
Positive Regulation Of Fibroblast Proliferation (GO:0048146),1/28,0.12489094195154,0.231292442776175,0,0,7.83215130023641,16.2933370301504,CDK6
Positive Regulation Of Peptidyl-Tyrosine Phosphorylation (GO:0050731),2/130,0.126968590559242,0.234485168637262,0,0,3.32274865591398,6.85754031671625,PARP9;IL6ST
Positive Regulation Of Neural Precursor Cell Proliferation (GO:2000179),1/29,0.129053531185095,0.235709342081867,0,0,7.55205167173252,15.4630371818361,HAPLN3
Integrated Stress Response Signaling (GO:0140467),1/29,0.129053531185095,0.235709342081867,0,0,7.55205167173252,15.4630371818361,EIF2AK2
Positive Regulation Of Viral Genome Replication (GO:0045070),1/29,0.129053531185095,0.235709342081867,0,0,7.55205167173252,15.4630371818361,IFIT1
Modified Amino Acid Transport (GO:0072337),1/29,0.129053531185095,0.235709342081867,0,0,7.55205167173252,15.4630371818361,SLC7A11
Positive Regulation Of Interleukin-10 Production (GO:0032733),1/30,0.133196527923111,0.238944179814351,0,0,7.29126925898753,14.698685432239,ISG15
Positive Regulation Of Lipid Kinase Activity (GO:0090218),1/30,0.133196527923111,0.238944179814351,0,0,7.29126925898753,14.698685432239,IRS1
GPI Anchor Biosynthetic Process (GO:0006506),1/30,0.133196527923111,0.238944179814351,0,0,7.29126925898753,14.698685432239,PGAP1
Negative Regulation Of Myeloid Leukocyte Differentiation (GO:0002762),1/30,0.133196527923111,0.238944179814351,0,0,7.29126925898753,14.698685432239,CDK6
Mitotic G2 DNA Damage Checkpoint Signaling (GO:0007095),1/30,0.133196527923111,0.238944179814351,0,0,7.29126925898753,14.698685432239,TNFSF13B
Regulation Of Calcium-Mediated Signaling (GO:0050848),1/30,0.133196527923111,0.238944179814351,0,0,7.29126925898753,14.698685432239,GBP1
Antigen Receptor-Mediated Signaling Pathway (GO:0050851),2/134,0.133347430665626,0.238944179814351,0,0,3.22140762463343,6.4904833718733,CD38;TNFRSF21
Positive Regulation Of Glucose Transmembrane Transport (GO:0010828),1/31,0.137320023403216,0.242136105096629,0,0,7.04787234042553,13.9931356938976,IRS1
Toll-Like Receptor Signaling Pathway (GO:0002224),1/31,0.137320023403216,0.242136105096629,0,0,7.04787234042553,13.9931356938976,TLR7
Regulation Of Response To Biotic Stimulus (GO:0002831),1/31,0.137320023403216,0.242136105096629,0,0,7.04787234042553,13.9931356938976,HERC5
Phospholipid Translocation (GO:0045332),1/31,0.137320023403216,0.242136105096629,0,0,7.04787234042553,13.9931356938976,PLSCR1
Receptor Signaling Pathway Via STAT (GO:0097696),1/31,0.137320023403216,0.242136105096629,0,0,7.04787234042553,13.9931356938976,STAT1
Positive Regulation Of Rho Protein Signal Transduction (GO:0035025),1/31,0.137320023403216,0.242136105096629,0,0,7.04787234042553,13.9931356938976,LPAR6
Negative Regulation Of Cellular Biosynthetic Process (GO:0031327),2/137,0.138178965595381,0.243004387771187,0,0,3.14934289127837,6.23319702964363,GFI1;EIF2AK2
Negative Regulation Of Osteoblast Differentiation (GO:0045668),1/32,0.141424108472395,0.247398902156195,0,0,6.82017844886754,13.3402147687031,CDK6
Phosphatidylinositol 3-Kinase Signaling (GO:0014065),1/32,0.141424108472395,0.247398902156195,0,0,6.82017844886754,13.3402147687031,IRS1
Negative Regulation Of Endocytosis (GO:0045806),1/33,0.145508873471312,0.251230164352811,0,0,6.60671542553191,12.7345642789305,PLSCR1
Glycolipid Metabolic Process (GO:0006664),1/33,0.145508873471312,0.251230164352811,0,0,6.60671542553191,12.7345642789305,PGAP1
Ubiquitin-Dependent Protein Catabolic Process Via The Multivesicular Body Sorting Pathway (GO:0043162),1/33,0.145508873471312,0.251230164352811,0,0,6.60671542553191,12.7345642789305,MVB12B
Positive Regulation Of Small Molecule Metabolic Process (GO:0062013),1/33,0.145508873471312,0.251230164352811,0,0,6.60671542553191,12.7345642789305,IRS1
Positive Regulation Of Notch Signaling Pathway (GO:0045747),1/33,0.145508873471312,0.251230164352811,0,0,6.60671542553191,12.7345642789305,IL6ST
DNA Damage Checkpoint Signaling (GO:0000077),1/34,0.149574408433877,0.253626170822662,0,0,6.40618955512573,12.1715122012105,PARP9
Glial Cell Differentiation (GO:0010001),1/34,0.149574408433877,0.253626170822662,0,0,6.40618955512573,12.1715122012105,HAPLN3
Regulation Of Phosphatidylinositol 3-Kinase Activity (GO:0043551),1/34,0.149574408433877,0.253626170822662,0,0,6.40618955512573,12.1715122012105,IRS1
Purine Nucleotide Metabolic Process (GO:0006163),1/34,0.149574408433877,0.253626170822662,0,0,6.40618955512573,12.1715122012105,CD38
Cellular Response To Vascular Endothelial Growth Factor Stimulus (GO:0035924),1/34,0.149574408433877,0.253626170822662,0,0,6.40618955512573,12.1715122012105,GAB1
Regulation Of T Cell Receptor Signaling Pathway (GO:0050856),1/34,0.149574408433877,0.253626170822662,0,0,6.40618955512573,12.1715122012105,GBP1
Positive Regulation Of Carbohydrate Metabolic Process (GO:0045913),1/34,0.149574408433877,0.253626170822662,0,0,6.40618955512573,12.1715122012105,IRS1
Regulation Of Cellular Senescence (GO:2000772),1/35,0.153620802905651,0.257198465470824,0,0,6.21745932415519,11.6469677913017,CDK6
Neutral Amino Acid Transport (GO:0015804),1/35,0.153620802905651,0.257198465470824,0,0,6.21745932415519,11.6469677913017,SLC7A11
Macrophage Activation (GO:0042116),1/35,0.153620802905651,0.257198465470824,0,0,6.21745932415519,11.6469677913017,IFI35
Response To Exogenous dsRNA (GO:0043330),1/35,0.153620802905651,0.257198465470824,0,0,6.21745932415519,11.6469677913017,IFIT1
Dendrite Morphogenesis (GO:0048813),1/35,0.153620802905651,0.257198465470824,0,0,6.21745932415519,11.6469677913017,BTBD3
Regulation Of Glucose Import (GO:0046324),1/36,0.157648146044022,0.2606501766264,0,0,6.03951367781155,11.1573350775974,IRS1
Positive Regulation Of Myeloid Cell Differentiation (GO:0045639),1/36,0.157648146044022,0.2606501766264,0,0,6.03951367781155,11.1573350775974,STAT1
Regulation Of Intracellular Protein Transport (GO:0033157),1/36,0.157648146044022,0.2606501766264,0,0,6.03951367781155,11.1573350775974,IFI27
Receptor Signaling Pathway Via JAK-STAT (GO:0007259),1/36,0.157648146044022,0.2606501766264,0,0,6.03951367781155,11.1573350775974,STAT1
Negative Regulation Of T Cell Proliferation (GO:0042130),1/36,0.157648146044022,0.2606501766264,0,0,6.03951367781155,11.1573350775974,TNFRSF21
Negative Regulation Of Endothelial Cell Proliferation (GO:0001937),1/37,0.161656526562578,0.265951059828757,0,0,5.87145390070922,10.6994412399341,STAT1
Positive Regulation Of Immune Effector Process (GO:0002699),1/37,0.161656526562578,0.265951059828757,0,0,5.87145390070922,10.6994412399341,DDX60
Tumor Necrosis Factor-Mediated Signaling Pathway (GO:0033209),1/38,0.165646032857741,0.268516674290177,0,0,5.71247843588269,10.2704769730227,STAT1
Regulation Of Intracellular Transport (GO:0032386),1/38,0.165646032857741,0.268516674290177,0,0,5.71247843588269,10.2704769730227,MX2
Negative Regulation Of Type I Interferon Production (GO:0032480),1/38,0.165646032857741,0.268516674290177,0,0,5.71247843588269,10.2704769730227,XAF1
Regulation Of Neurotransmitter Secretion (GO:0046928),1/38,0.165646032857741,0.268516674290177,0,0,5.71247843588269,10.2704769730227,MYOF
Response To cAMP (GO:0051591),1/38,0.165646032857741,0.268516674290177,0,0,5.71247843588269,10.2704769730227,STAT1
Positive Regulation Of Bone Mineralization (GO:0030501),1/38,0.165646032857741,0.268516674290177,0,0,5.71247843588269,10.2704769730227,ISG15
Regulation Of Cell Cycle (GO:0051726),3/298,0.168833541761583,0.270326699762869,0,0,2.16764922623434,3.8559055053591,CDK6;MX2;TNFSF13B
Positive Regulation Of Intracellular Transport (GO:0032388),1/39,0.169616752792388,0.270326699762869,0,0,5.56187010078387,9.86794658787036,PGAP1
Negative Regulation Of Lymphocyte Proliferation (GO:0050672),1/39,0.169616752792388,0.270326699762869,0,0,5.56187010078387,9.86794658787036,TNFRSF21
Negative Regulation Of Proteasomal Protein Catabolic Process (GO:1901799),1/39,0.169616752792388,0.270326699762869,0,0,5.56187010078387,9.86794658787036,LAMP3
Carboxylic Acid Transmembrane Transport (GO:1905039),1/39,0.169616752792388,0.270326699762869,0,0,5.56187010078387,9.86794658787036,SLC7A11
Positive Regulation Of ATP-dependent Activity (GO:0032781),1/39,0.169616752792388,0.270326699762869,0,0,5.56187010078387,9.86794658787036,PLSCR1
Negative Regulation Of Cell-Substrate Adhesion (GO:0010812),1/39,0.169616752792388,0.270326699762869,0,0,5.56187010078387,9.86794658787036,GBP1
L-alpha-amino Acid Transmembrane Transport (GO:1902475),1/40,0.173568773952628,0.27464462322337,0,0,5.4189852700491,9.48962603013873,SLC7A11
Negative Regulation Of Secretion By Cell (GO:1903531),1/40,0.173568773952628,0.27464462322337,0,0,5.4189852700491,9.48962603013873,RSAD2
Endothelial Cell Migration (GO:0043542),1/40,0.173568773952628,0.27464462322337,0,0,5.4189852700491,9.48962603013873,STAT1
Response To Lipopolysaccharide (GO:0032496),2/159,0.174654559504352,0.275704697503299,0,0,2.70502020409561,4.72011202522279,GFI1;GBP2
Positive Regulation Of Ossification (GO:0045778),1/41,0.177502183410305,0.278212642082818,0,0,5.28324468085106,9.13352742418527,ISG15
Positive Regulation Of Viral Process (GO:0048524),1/41,0.177502183410305,0.278212642082818,0,0,5.28324468085106,9.13352742418527,IFIT1
Response To Amino Acid Starvation (GO:1990928),1/41,0.177502183410305,0.278212642082818,0,0,5.28324468085106,9.13352742418527,EIF2AK2
Substantia Nigra Development (GO:0021762),1/42,0.181417067914516,0.280371832231525,0,0,5.15412558380903,8.79786897006337,GNB4
DNA Integrity Checkpoint Signaling (GO:0031570),1/42,0.181417067914516,0.280371832231525,0,0,5.15412558380903,8.79786897006337,PARP9
Amino Acid Transmembrane Transport (GO:0003333),1/42,0.181417067914516,0.280371832231525,0,0,5.15412558380903,8.79786897006337,SLC7A11
Cellular Response To Amino Acid Starvation (GO:0034198),1/42,0.181417067914516,0.280371832231525,0,0,5.15412558380903,8.79786897006337,EIF2AK2
Ceramide Biosynthetic Process (GO:0046513),1/42,0.181417067914516,0.280371832231525,0,0,5.15412558380903,8.79786897006337,CERS6
Negative Regulation Of I-kappaB kinase/NF-kappaB Signaling (GO:0043124),1/42,0.181417067914516,0.280371832231525,0,0,5.15412558380903,8.79786897006337,STAT1
Positive Regulation Of miRNA Transcription (GO:1902895),1/43,0.185313513783342,0.28440476768138,0,0,5.03115501519757,8.48104929855628,MYB
Positive Regulation Of Biomineral Tissue Development (GO:0070169),1/43,0.185313513783342,0.28440476768138,0,0,5.03115501519757,8.48104929855628,ISG15
Positive Regulation Of Cell-Matrix Adhesion (GO:0001954),1/43,0.185313513783342,0.28440476768138,0,0,5.03115501519757,8.48104929855628,CDK6
Regulation Of Insulin Receptor Signaling Pathway (GO:0046626),1/44,0.189191606908905,0.288354104323228,0,0,4.91390400791687,8.18162552648832,IRS1
Neural Crest Cell Development (GO:0014032),1/44,0.189191606908905,0.288354104323228,0,0,4.91390400791687,8.18162552648832,TAPT1
Regulation Of Viral Entry Into Host Cell (GO:0046596),1/44,0.189191606908905,0.288354104323228,0,0,4.91390400791687,8.18162552648832,IFITM1
Double-Strand Break Repair (GO:0006302),2/168,0.189997567010718,0.288918318642445,0,0,2.55719652804767,4.24684882174464,BRCA2;PARP9
Epidermal Growth Factor Receptor Signaling Pathway (GO:0007173),1/45,0.193051432861237,0.290735211306774,0,0,4.80198259187621,7.89829440794978,GAB1
I-kappaB kinase/NF-kappaB Signaling (GO:0007249),1/45,0.193051432861237,0.290735211306774,0,0,4.80198259187621,7.89829440794978,TLR7
Hexose Metabolic Process (GO:0019318),1/45,0.193051432861237,0.290735211306774,0,0,4.80198259187621,7.89829440794978,OAS1
Regulation Of Stem Cell Differentiation (GO:2000736),1/45,0.193051432861237,0.290735211306774,0,0,4.80198259187621,7.89829440794978,EIF2AK2
Proteasome-Mediated Ubiquitin-Dependent Protein Catabolic Process (GO:0043161),3/319,0.193693207446493,0.290735211306774,0,0,2.02142955421024,3.3181357330059,IFI27;MAN1A1;TNFSF13B
Epithelial Cell Migration (GO:0010631),1/46,0.196893076737167,0.290735211306774,0,0,4.69503546099291,7.62987609495454,STAT1
B Cell Receptor Signaling Pathway (GO:0050853),1/46,0.196893076737167,0.290735211306774,0,0,4.69503546099291,7.62987609495454,CD38
Regulation Of Cytokine Production Involved In Inflammatory Response (GO:1900015),1/46,0.196893076737167,0.290735211306774,0,0,4.69503546099291,7.62987609495454,GBP5
Regulation Of Fibroblast Proliferation (GO:0048145),1/46,0.196893076737167,0.290735211306774,0,0,4.69503546099291,7.62987609495454,CDK6
Amino Acid Transport (GO:0006865),1/46,0.196893076737167,0.290735211306774,0,0,4.69503546099291,7.62987609495454,SLC7A11
Mitotic G2/M Transition Checkpoint (GO:0044818),1/46,0.196893076737167,0.290735211306774,0,0,4.69503546099291,7.62987609495454,TNFSF13B
Replication Fork Processing (GO:0031297),1/46,0.196893076737167,0.290735211306774,0,0,4.69503546099291,7.62987609495454,BRCA2
Negative Regulation Of Cellular Metabolic Process (GO:0031324),1/46,0.196893076737167,0.290735211306774,0,0,4.69503546099291,7.62987609495454,CDK6
Positive Regulation Of Cell Population Proliferation (GO:0008284),4/483,0.197355209483853,0.290770008639543,0,0,1.78265158640942,2.89279800452888,CDK6;IRS1;STAT1;IL6ST
Regulation Of Interleukin-2 Production (GO:0032663),1/47,0.200716623291285,0.293117007141237,0,0,4.5927382053654,7.37530008596669,GBP1
Positive Regulation Of Smooth Muscle Cell Proliferation (GO:0048661),1/47,0.200716623291285,0.293117007141237,0,0,4.5927382053654,7.37530008596669,STAT1
Protein Monoubiquitination (GO:0006513),1/47,0.200716623291285,0.293117007141237,0,0,4.5927382053654,7.37530008596669,TNFSF13B
Cognition (GO:0050890),1/47,0.200716623291285,0.293117007141237,0,0,4.5927382053654,7.37530008596669,GPR155
Post-Translational Protein Modification (GO:0043687),1/48,0.204522156887535,0.294778673948773,0,0,4.49479402444545,7.13359303800207,PARP9
Cellular Defense Response (GO:0006968),1/48,0.204522156887535,0.294778673948773,0,0,4.49479402444545,7.13359303800207,LGALS3BP
Cellular Response To Mechanical Stimulus (GO:0071260),1/48,0.204522156887535,0.294778673948773,0,0,4.49479402444545,7.13359303800207,TLR7
Cellular Response To Radiation (GO:0071478),1/48,0.204522156887535,0.294778673948773,0,0,4.49479402444545,7.13359303800207,BRCA2
Myelination (GO:0042552),1/48,0.204522156887535,0.294778673948773,0,0,4.49479402444545,7.13359303800207,TNFRSF21
Negative Regulation Of ERK1 And ERK2 Cascade (GO:0070373),1/48,0.204522156887535,0.294778673948773,0,0,4.49479402444545,7.13359303800207,GBP1
Erythrocyte Differentiation (GO:0030218),1/49,0.208309761448004,0.298292379784075,0,0,4.40093085106383,6.90386815832825,MYB
Positive Regulation Of miRNA Metabolic Process (GO:2000630),1/49,0.208309761448004,0.298292379784075,0,0,4.40093085106383,6.90386815832825,MYB
Negative Regulation Of T Cell Activation (GO:0050868),1/49,0.208309761448004,0.298292379784075,0,0,4.40093085106383,6.90386815832825,TNFRSF21
Negative Regulation Of Cell Projection Organization (GO:0031345),1/50,0.21207952058325,0.303036039109256,0,0,4.31089882761615,6.68531593969729,GFI1
Protein Phosphorylation (GO:0006468),4/500,0.214076276120009,0.305109373261584,0,0,1.72004608294931,2.65131841615186,CDK6;EIF2AK2;SGK3;TLR7
Amide Biosynthetic Process (GO:0043604),1/51,0.215831517435419,0.305109373261584,0,0,4.22446808510638,6.47719605501669,CERS6
Regulation Of Stress-Activated MAPK Cascade (GO:0032872),1/51,0.215831517435419,0.305109373261584,0,0,4.22446808510638,6.47719605501669,EIF2AK2
Regulation Of Substrate Adhesion-Dependent Cell Spreading (GO:1900024),1/51,0.215831517435419,0.305109373261584,0,0,4.22446808510638,6.47719605501669,GBP1
Positive Regulation Of Ras Protein Signal Transduction (GO:0046579),1/51,0.215831517435419,0.305109373261584,0,0,4.22446808510638,6.47719605501669,LPAR6
Regulation Of Protein Localization To Nucleus (GO:1900180),1/52,0.21956583482927,0.308415568838572,0,0,4.14142678347935,6.27883023562828,PARP9
Cell Cycle G1/S Phase Transition (GO:0044843),1/52,0.21956583482927,0.308415568838572,0,0,4.14142678347935,6.27883023562828,CDK6
Cellular Response To Ionizing Radiation (GO:0071479),1/52,0.21956583482927,0.308415568838572,0,0,4.14142678347935,6.27883023562828,BRCA2
Regulation Of Cyclin-Dependent Protein Kinase Activity (GO:1904029),1/53,0.223282555248102,0.311000701952714,0,0,4.06157937806874,6.08959600622538,HERC5
Glycoprotein Metabolic Process (GO:0009100),1/53,0.223282555248102,0.311000701952714,0,0,4.06157937806874,6.08959600622538,MAN1A1
Regulation Of Proteasomal Protein Catabolic Process (GO:0061136),1/53,0.223282555248102,0.311000701952714,0,0,4.06157937806874,6.08959600622538,LAMP3
Protein Homotetramerization (GO:0051289),1/53,0.223282555248102,0.311000701952714,0,0,4.06157937806874,6.08959600622538,GBP5
ERBB Signaling Pathway (GO:0038127),1/54,0.226981760663197,0.312217650040871,0,0,3.98474508229627,5.90892115891192,GAB1
Negative Regulation Of Neuron Projection Development (GO:0010977),1/54,0.226981760663197,0.312217650040871,0,0,3.98474508229627,5.90892115891192,GFI1
Negative Regulation Of Protein Catabolic Process (GO:0042177),1/54,0.226981760663197,0.312217650040871,0,0,3.98474508229627,5.90892115891192,LAMP3
Negative Regulation Of Protein Modification By Small Protein Conjugation Or Removal (GO:1903321),1/54,0.226981760663197,0.312217650040871,0,0,3.98474508229627,5.90892115891192,ISG15
Negative Regulation Of Protein Ubiquitination (GO:0031397),1/54,0.226981760663197,0.312217650040871,0,0,3.98474508229627,5.90892115891192,ISG15
Regulation Of Smooth Muscle Cell Proliferation (GO:0048660),1/54,0.226981760663197,0.312217650040871,0,0,3.98474508229627,5.90892115891192,STAT1
Ceramide Metabolic Process (GO:0006672),1/55,0.230663532751129,0.31662509775155,0,0,3.91075650118203,5.73627885829532,CERS6
Regulation Of Cell Differentiation (GO:0045595),2/193,0.233417710216784,0.319013208850531,0,0,2.21967010077127,3.22945503686455,CDK6;EIF2AK2
Nucleotide-Excision Repair (GO:0006289),1/56,0.234327952805745,0.319013208850531,0,0,3.8394584139265,5.57118330686493,BRCA2
Pattern Recognition Receptor Signaling Pathway (GO:0002221),1/56,0.234327952805745,0.319013208850531,0,0,3.8394584139265,5.57118330686493,TLR7
Mitotic DNA Damage Checkpoint Signaling (GO:0044773),1/56,0.234327952805745,0.319013208850531,0,0,3.8394584139265,5.57118330686493,TNFSF13B
Positive Regulation Of Interleukin-1 Beta Production (GO:0032731),1/57,0.237975101725458,0.320685960251989,0,0,3.77070668693009,5.41318589183295,GBP5
Post-Transcriptional Regulation Of Gene Expression (GO:0010608),1/57,0.237975101725458,0.320685960251989,0,0,3.77070668693009,5.41318589183295,PARP9
Membrane Lipid Biosynthetic Process (GO:0046467),1/57,0.237975101725458,0.320685960251989,0,0,3.77070668693009,5.41318589183295,CERS6
Myeloid Cell Differentiation (GO:0030099),1/57,0.237975101725458,0.320685960251989,0,0,3.77070668693009,5.41318589183295,MYB
Signal Transduction In Response To DNA Damage (GO:0042770),1/57,0.237975101725458,0.320685960251989,0,0,3.77070668693009,5.41318589183295,PARP9
Glycosaminoglycan Biosynthetic Process (GO:0006024),1/58,0.241605060070884,0.322951925054428,0,0,3.7043673012318,5.26187175264405,HS3ST1
Regulation Of Phagocytosis (GO:0050764),1/58,0.241605060070884,0.322951925054428,0,0,3.7043673012318,5.26187175264405,PLSCR1
Renal System Development (GO:0072001),1/58,0.241605060070884,0.322951925054428,0,0,3.7043673012318,5.26187175264405,STAT1
Regulation Of Bone Mineralization (GO:0030500),1/58,0.241605060070884,0.322951925054428,0,0,3.7043673012318,5.26187175264405,ISG15
Glucose Metabolic Process (GO:0006006),1/59,0.245217908039138,0.325810567194285,0,0,3.64031548055759,5.11685671914656,OAS1
Regulation Of miRNA Transcription (GO:1902893),1/59,0.245217908039138,0.325810567194285,0,0,3.64031548055759,5.11685671914656,MYB
Regulation Of Multicellular Organismal Development (GO:2000026),1/59,0.245217908039138,0.325810567194285,0,0,3.64031548055759,5.11685671914656,OAS2
protein-DNA Complex Organization (GO:0071824),1/60,0.248813725343768,0.329268462880077,0,0,3.57843490804183,4.97778457506065,SATB1
Response To Light Stimulus (GO:0009416),1/60,0.248813725343768,0.329268462880077,0,0,3.57843490804183,4.97778457506065,TNFSF13B
Protein Modification By Small Protein Conjugation (GO:0032446),3/364,0.249593645114111,0.329642603009274,0,0,1.76538600505841,2.45021649152206,HERC5;ISG15;HERC6
Positive Regulation Of Interleukin-8 Production (GO:0032757),1/61,0.252392591460855,0.332016444719339,0,0,3.5186170212766,4.84432460101412,TLR7
Positive Regulation Of Organelle Assembly (GO:1902117),1/61,0.252392591460855,0.332016444719339,0,0,3.5186170212766,4.84432460101412,TAPT1
Regulation Of Angiogenesis (GO:0045765),2/205,0.254498697537934,0.334124032609209,0,0,2.08718682133588,2.85623076069466,STAT1;GAB1
Phosphatidylinositol-Mediated Signaling (GO:0048015),1/62,0.255954585486716,0.335371324461844,0,0,3.46076037670038,4.71616937470208,IRS1
Negative Regulation Of Cell Differentiation (GO:0045596),2/207,0.258018685829703,0.337349721902396,0,0,2.06661421452924,2.79969036857448,CDK6;MYB
Positive Regulation Of Mitotic Cell Cycle Phase Transition (GO:1901992),1/63,0.259499786078766,0.337349721902396,0,0,3.4047700754976,4.5930327914895,TNFSF13B
Phosphatidylinositol Metabolic Process (GO:0046488),1/63,0.259499786078766,0.337349721902396,0,0,3.4047700754976,4.5930327914895,PGAP1
Regulation Of Cellular Catabolic Process (GO:0031329),1/63,0.259499786078766,0.337349721902396,0,0,3.4047700754976,4.5930327914895,LAMP3
Positive Regulation Of Interleukin-1 Production (GO:0032732),1/64,0.263028271570765,0.339937122907246,0,0,3.35055724417427,4.47464827910033,GBP5
Regulation Of Secretion By Cell (GO:1903530),1/64,0.263028271570765,0.339937122907246,0,0,3.35055724417427,4.47464827910033,MYOF
Response To Metal Ion (GO:0010038),1/64,0.263028271570765,0.339937122907246,0,0,3.35055724417427,4.47464827910033,PLSCR1
Positive Regulation Of T Cell Proliferation (GO:0042102),1/65,0.266540119989744,0.343138057384855,0,0,3.29803856382979,4.36076718802917,IL6ST
Regulation Of Cell-Matrix Adhesion (GO:0001952),1/65,0.266540119989744,0.343138057384855,0,0,3.29803856382979,4.36076718802917,CDK6
Extrinsic Apoptotic Signaling Pathway (GO:0097191),1/67,0.273514215491603,0.351433962928165,0,0,3.19777562862669,4.1456017044657,IFI27
Proteasomal Protein Catabolic Process (GO:0010498),2/220,0.280906972506813,0.360234666870439,0,0,1.94209332149551,2.46593749963038,IFI27;TNFSF13B
Negative Regulation Of Extrinsic Apoptotic Signaling Pathway (GO:2001237),1/70,0.283852509171129,0.361911949193189,0,0,3.05827937095282,3.85129277041947,IFI6
Protein K48-linked Ubiquitination (GO:0070936),1/70,0.283852509171129,0.361911949193189,0,0,3.05827937095282,3.85129277041947,IFI27
Regulation Of Notch Signaling Pathway (GO:0008593),1/70,0.283852509171129,0.361911949193189,0,0,3.05827937095282,3.85129277041947,IL6ST
Regulation Of Cilium Assembly (GO:1902017),1/71,0.287266152286331,0.364163401464317,0,0,3.01443768996961,3.76004719597113,TAPT1
Protein Autoubiquitination (GO:0051865),1/71,0.287266152286331,0.364163401464317,0,0,3.01443768996961,3.76004719597113,BRCA2
Positive Regulation Of Cell-Substrate Adhesion (GO:0010811),1/71,0.287266152286331,0.364163401464317,0,0,3.01443768996961,3.76004719597113,CDK6
Positive Regulation Of Protein Localization To Nucleus (GO:1900182),1/72,0.290663694101236,0.36706672226499,0,0,2.97183098591549,3.67195980531694,PARP9
Response To Ionizing Radiation (GO:0010212),1/72,0.290663694101236,0.36706672226499,0,0,2.97183098591549,3.67195980531694,BRCA2
Protein Polyubiquitination (GO:0000209),2/226,0.291460170174123,0.367372800048372,0,0,1.88949692780338,2.32946991529333,IFI27;TNFSF13B
Ubiquitin-Dependent ERAD Pathway (GO:0030433),1/73,0.294045209826092,0.368529251634592,0,0,2.93040780141844,3.58688288104775,MAN1A1
Protein Tetramerization (GO:0051262),1/73,0.294045209826092,0.368529251634592,0,0,2.93040780141844,3.58688288104775,GBP5
Regulation Of Rho Protein Signal Transduction (GO:0035023),1/73,0.294045209826092,0.368529251634592,0,0,2.93040780141844,3.58688288104775,LPAR6
Negative Regulation Of Neuron Apoptotic Process (GO:0043524),1/74,0.297410774156585,0.372044043897766,0,0,2.89011949868843,3.50467745040254,IL6ST
Negative Regulation Of Intracellular Signal Transduction (GO:1902532),2/231,0.300241328000262,0.374819898582846,0,0,1.84777198666479,2.2231814210064,STAT1;IFI35
Positive Regulation Of Neurogenesis (GO:0050769),1/75,0.300760461607955,0.374819898582846,0,0,2.85092006900518,3.42521265680931,HAPLN3
Cellular Response To Oxygen-Containing Compound (GO:1901701),3/406,0.303708892700483,0.377555340064125,0,0,1.57800194195706,1.88048223228118,IRS1;GFI1;GBP2
Positive Regulation Of Interleukin-6 Production (GO:0032755),1/76,0.304094346295992,0.377555340064125,0,0,2.81276595744681,3.34836518927652,TLR7
Sphingolipid Biosynthetic Process (GO:0030148),1/77,0.307412501907002,0.379542809617025,0,0,2.77561590145577,3.27401875703022,CERS6
Positive Regulation Of Response To Stimulus (GO:0048584),1/77,0.307412501907002,0.379542809617025,0,0,2.77561590145577,3.27401875703022,RSAD2
Negative Regulation Of Blood Vessel Morphogenesis (GO:2000181),1/77,0.307412501907002,0.379542809617025,0,0,2.77561590145577,3.27401875703022,STAT1
Proteolysis Involved In Protein Catabolic Process (GO:0051603),1/78,0.310715001943329,0.382907149234995,0,0,2.73943078198397,3.20206360450238,ISG15
Regulation Of Cyclin-Dependent Protein Serine/Threonine Kinase Activity (GO:0000079),1/79,0.314001919471991,0.384101978985111,0,0,2.70417348608838,3.13239606973913,HERC5
Vesicle Fusion (GO:0006906),1/79,0.314001919471991,0.384101978985111,0,0,2.70417348608838,3.13239606973913,SAMD9
Response To Insulin (GO:0032868),1/79,0.314001919471991,0.384101978985111,0,0,2.70417348608838,3.13239606973913,IRS1
Positive Regulation Of Catabolic Process (GO:0009896),1/79,0.314001919471991,0.384101978985111,0,0,2.70417348608838,3.13239606973913,TNFSF13B
Wound Healing (GO:0042060),1/80,0.317273327187397,0.386676867509641,0,0,2.66980877996229,3.06491817511279,MYOF
Regulation Of Protein Localization To Plasma Membrane (GO:1903076),1/80,0.317273327187397,0.386676867509641,0,0,2.66980877996229,3.06491817511279,GBP1
Regulation Of Interleukin-8 Production (GO:0032677),1/81,0.320529297553162,0.389214147028839,0,0,2.63630319148936,2.99953724952817,TLR7
Negative Regulation Of NF-kappaB Transcription Factor Activity (GO:0032088),1/81,0.320529297553162,0.389214147028839,0,0,2.63630319148936,2.99953724952817,GFI1
Phospholipase C-activating G Protein-Coupled Receptor Signaling Pathway (GO:0007200),1/83,0.32699521413788,0.396339720243903,0,0,2.57174364296834,2.87472010280964,LPAR6
Regulation Of Interleukin-1 Beta Production (GO:0032651),1/84,0.330205303529414,0.399500212116791,0,0,2.54063060753653,2.81512208139504,GBP5
Positive Regulation Of Protein Localization (GO:1903829),1/85,0.333400241883353,0.400743129121284,0,0,2.51025835866261,2.7572968578811,PARP9
Integrin-Mediated Signaling Pathway (GO:0007229),1/85,0.333400241883353,0.400743129121284,0,0,2.51025835866261,2.7572968578811,ISG15
Negative Regulation Of Cell Cycle (GO:0045786),1/85,0.333400241883353,0.400743129121284,0,0,2.51025835866261,2.7572968578811,CDK6
Phosphorylation (GO:0016310),3/429,0.33365038804668,0.400743129121284,0,0,1.49104409063074,1.63666180729893,CDK6;EIF2AK2;SGK3
Regulation Of Mitotic Cell Cycle Phase Transition (GO:1901990),1/86,0.336580099919151,0.402802538350897,0,0,2.48060075093867,2.70117358636494,CDK6
Negative Regulation Of Angiogenesis (GO:0016525),1/86,0.336580099919151,0.402802538350897,0,0,2.48060075093867,2.70117358636494,STAT1
Regulation Of Insulin Secretion (GO:0050796),1/87,0.339744948059646,0.405857478492874,0,0,2.45163285502227,2.64668499944949,IRS1
Negative Regulation Of Neuron Death (GO:1901215),1/88,0.342894856457677,0.408149532911023,0,0,2.42333088774762,2.59376718960497,IL6ST
Positive Regulation Of Plasma Membrane Bounded Cell Projection Assembly (GO:0120034),1/88,0.342894856457677,0.408149532911023,0,0,2.42333088774762,2.59376718960497,TAPT1
ERAD Pathway (GO:0036503),1/89,0.346029894810234,0.41040754965865,0,0,2.39567214700193,2.54235940763279,MAN1A1
Cellular Response To Peptide Hormone Stimulus (GO:0071375),1/89,0.346029894810234,0.41040754965865,0,0,2.39567214700193,2.54235940763279,IRS1
Regulation Of Epithelial Cell Proliferation (GO:0050678),1/91,0.352255639035053,0.416302118859608,0,0,2.34219858156028,2.44384559599983,CDK6
Positive Regulation Of Binding (GO:0051099),1/91,0.352255639035053,0.416302118859608,0,0,2.34219858156028,2.44384559599983,PARP9
Positive Regulation Of Protein Catabolic Process (GO:0045732),1/92,0.355346482879335,0.419207683539144,0,0,2.31634323123685,2.39663222160041,TNFSF13B
Regulation Of Endothelial Cell Proliferation (GO:0001936),1/93,0.35842273256095,0.421337361148776,0,0,2.29104995374653,2.35071387067599,STAT1
Negative Regulation Of Amide Metabolic Process (GO:0034249),1/93,0.35842273256095,0.421337361148776,0,0,2.29104995374653,2.35071387067599,EIF2AK2
Positive Regulation Of Signal Transduction (GO:0009967),2/266,0.361033300500429,0.422688173843481,0,0,1.59995112414467,1.63000633360789,IRS1;IL6ST
Sphingolipid Metabolic Process (GO:0006665),1/94,0.361484456363882,0.422688173843481,0,0,2.26630061770762,2.30604300000091,CERS6
Muscle Contraction (GO:0006936),1/94,0.361484456363882,0.422688173843481,0,0,2.26630061770762,2.30604300000091,MYOF
T Cell Receptor Signaling Pathway (GO:0050852),1/95,0.364531722088323,0.424753131361262,0,0,2.24207786328655,2.26257427158187,TNFRSF21
Recombinational Repair (GO:0000725),1/95,0.364531722088323,0.424753131361262,0,0,2.24207786328655,2.26257427158187,BRCA2
Negative Regulation Of Nucleic Acid-Templated Transcription (GO:1903507),3/456,0.368754157415621,0.428919309415012,0,0,1.40023034840196,1.39690493720876,GFI1;MYB;CD38
Negative Regulation Of Macromolecule Biosynthetic Process (GO:0010558),1/98,0.373587444838632,0.433780168000022,0,0,2.17240622943628,2.13895807976583,EIF2AK2
Positive Regulation Of DNA-templated Transcription (GO:0045893),7/1243,0.377700552259747,0.437789276482889,0,0,1.20148389232127,1.16982910160114,PLSCR1;STAT1;MYB;IRF7;CD38;BRCA2;PARP9
Response To UV (GO:0009411),1/100,0.379553533216983,0.439169271418603,0,0,2.12830431979368,2.06181530451832,TNFSF13B
Hemopoiesis (GO:0030097),1/101,0.382515458258768,0.441825346385998,0,0,2.10691489361702,2.02471616427469,MYB
Regulation Of Protein Secretion (GO:0050708),1/102,0.385463391639877,0.444456049838675,0,0,2.08594902043396,1.98855408696316,RSAD2
Positive Regulation Of Cell Differentiation (GO:0045597),2/283,0.389906126816149,0.448798198054005,0,0,1.50185589101902,1.41452187355447,IFITM1;IL6ST
Positive Regulation Of Vasculature Development (GO:1904018),1/104,0.391317544490511,0.449090105914796,0,0,2.04523858706879,1.91891629580753,GAB1
Transmembrane Receptor Protein Tyrosine Kinase Signaling Pathway (GO:0007169),2/284,0.391587503183867,0.449090105914796,0,0,1.49645390070922,1.40299478934493,IRS1;GAB1
Positive Regulation Of Stress-Activated MAPK Cascade (GO:0032874),1/105,0.394223893879957,0.449090105914796,0,0,2.0254705400982,1.88538144761045,EIF2AK2
Intrinsic Apoptotic Signaling Pathway (GO:0097193),1/105,0.394223893879957,0.449090105914796,0,0,2.0254705400982,1.88538144761045,IFI6
Regulation Of Neuron Apoptotic Process (GO:0043523),1/105,0.394223893879957,0.449090105914796,0,0,2.0254705400982,1.88538144761045,IL6ST
Negative Regulation Of MAPK Cascade (GO:0043409),1/105,0.394223893879957,0.449090105914796,0,0,2.0254705400982,1.88538144761045,GBP1
Positive Regulation Of Gene Expression (GO:0010628),3/480,0.399711465495897,0.452554591528046,0,0,1.32813781788351,1.21791875284346,PLSCR1;LAMP3;EIF2AK2
Regulation Of Cellular Response To Stress (GO:0080135),1/107,0.399995460988589,0.452554591528046,0,0,1.98705339221196,1.82074115529591,BRCA2
Negative Regulation Of Translation (GO:0017148),1/107,0.399995460988589,0.452554591528046,0,0,1.98705339221196,1.82074115529591,EIF2AK2
Positive Regulation Of T Cell Activation (GO:0050870),1/107,0.399995460988589,0.452554591528046,0,0,1.98705339221196,1.82074115529591,IL6ST
Glycerophospholipid Biosynthetic Process (GO:0046474),1/108,0.402860806836591,0.454740879783242,0,0,1.96838337641678,1.78958363701266,PLSCR1
DNA Repair (GO:0006281),2/291,0.403299603789663,0.454740879783242,0,0,1.45968672098821,1.32550583589136,BRCA2;PARP9
Negative Regulation Of Developmental Process (GO:0051093),1/109,0.405712612443627,0.456684994991723,0,0,1.95005910165485,1.75916824744819,CDK6
Mitotic Cell Cycle Phase Transition (GO:0044772),1/111,0.411375855793142,0.461492711321241,0,0,1.91441005802708,1.70047088875305,CDK6
Double-Strand Break Repair Via Homologous Recombination (GO:0000724),1/111,0.411375855793142,0.461492711321241,0,0,1.91441005802708,1.70047088875305,BRCA2
Protein Deubiquitination (GO:0016579),1/112,0.414187419327281,0.463079694795931,0,0,1.897067280046,1.67214473041383,USP18
Regulation Of Protein Serine/Threonine Kinase Activity (GO:0071900),1/112,0.414187419327281,0.463079694795931,0,0,1.897067280046,1.67214473041383,HERC5
Regulation Of Protein Ubiquitination (GO:0031396),1/113,0.416985694107312,0.46542342625109,0,0,1.88003419452888,1.64447223527102,ISG15
Regulation Of Interleukin-6 Production (GO:0032675),1/114,0.419770742205874,0.466959735037742,0,0,1.86330257955187,1.61743341049361,TLR7
Protein Modification By Small Protein Removal (GO:0070646),1/114,0.419770742205874,0.466959735037742,0,0,1.86330257955187,1.61743341049361,USP18
Endoplasmic Reticulum To Golgi Vesicle-Mediated Transport (GO:0006888),1/115,0.422542625578718,0.469255880667822,0,0,1.84686450167973,1.59100903251231,PGAP1
Positive Regulation Of Cell Cycle Process (GO:0090068),1/118,0.430779901304577,0.477603803620292,0,0,1.79923622476814,1.51524116104146,PLSCR1
Regulation Of Protein-Containing Complex Assembly (GO:0043254),1/119,0.433499738345896,0.479017210872215,0,0,1.78389830508475,1.49109652691516,EIF2AK2
Positive Regulation Of Angiogenesis (GO:0045766),1/119,0.433499738345896,0.479017210872215,0,0,1.78389830508475,1.49109652691516,GAB1
Protein Modification Process (GO:0036211),4/711,0.43833120983122,0.483550070080031,0,0,1.19359000264234,0.984449720432362,PGAP1;CDK6;EIF2AK2;SGK3
Positive Regulation Of Macromolecule Biosynthetic Process (GO:0010557),1/122,0.441582331587087,0.48471702954013,0,0,1.73940566203622,1.42177417659347,IRS1
Regulation Of Protein Catabolic Process (GO:0042176),1/122,0.441582331587087,0.48471702954013,0,0,1.73940566203622,1.42177417659347,TNFSF13B
Protein Localization To Nucleus (GO:0034504),1/122,0.441582331587087,0.48471702954013,0,0,1.73940566203622,1.42177417659347,GBP2
Organonitrogen Compound Biosynthetic Process (GO:1901566),1/123,0.444251089500687,0.486037083067583,0,0,1.72506103941402,1.39965477040514,CERS6
Modulation Of Chemical Synaptic Transmission (GO:0050804),1/123,0.444251089500687,0.486037083067583,0,0,1.72506103941402,1.39965477040514,MYOF
Enzyme-Linked Receptor Protein Signaling Pathway (GO:0007167),1/124,0.44690722662515,0.488137547368162,0,0,1.71094966268812,1.37800613432938,IL6ST
Regulation Of Gene Expression (GO:0010468),6/1127,0.447655561590132,0.488150719299765,0,0,1.12964949032265,0.907934515594552,PLSCR1;CDK6;LAMP3;MYB;BRCA2;PARP9
Cellular Response To Starvation (GO:0009267),1/126,0.452181874494304,0.492276819030744,0,0,1.68340425531915,1.33606880689432,EIF2AK2
Positive Regulation Of Intracellular Signal Transduction (GO:1902533),3/525,0.456555512877368,0.496223450881468,0,0,1.21083208395802,0.949346818156416,EIF2AK2;TLR7;IFI35
Protein Homooligomerization (GO:0051260),1/129,0.460000657847614,0.498334046001582,0,0,1.64370013297872,1.27637812390166,GBP5
Protein Targeting (GO:0006605),1/129,0.460000657847614,0.498334046001582,0,0,1.64370013297872,1.27637812390166,MAN1A1
Protein-Containing Complex Assembly (GO:0065003),2/328,0.463334824835609,0.501127224903766,0,0,1.29157596147503,0.993616261525466,NT5C3A;GBP1
Negative Regulation Of Cell Motility (GO:2000146),1/133,0.470254179588674,0.507782607601451,0,0,1.59356866537718,1.20231875080952,IFITM1
Negative Regulation Of Gene Expression (GO:0010629),2/336,0.475858567287358,0.512998748148811,0,0,1.26012491146739,0.935812355103443,EIF2AK2;PARP9
Neuron Projection Morphogenesis (GO:0048812),1/146,0.502265855147247,0.539711931868112,0,0,1.44974321349963,0.998330446158999,BTBD3
Positive Regulation Of Cellular Catabolic Process (GO:0031331),1/146,0.502265855147247,0.539711931868112,0,0,1.44974321349963,0.998330446158999,IRS1
Negative Regulation Of Protein Metabolic Process (GO:0051248),1/147,0.504647472539326,0.541393647724229,0,0,1.43974060040804,0.984631639293697,EIF2AK2
Negative Regulation Of DNA-binding Transcription Factor Activity (GO:0043433),1/149,0.509376930630995,0.545584660756623,0,0,1.42014088556642,0.957980183568249,GFI1
Positive Regulation Of NF-kappaB Transcription Factor Activity (GO:0051092),1/152,0.516387464954477,0.552201434298094,0,0,1.39171480907426,0.91978138665967,EIF2AK2
Positive Regulation Of Macromolecule Metabolic Process (GO:0010604),2/364,0.518284856619783,0.552893192629787,0,0,1.16099328699578,0.763039933357495,PLSCR1;LAMP3
Regulation Of Cellular Component Organization (GO:0051128),1/153,0.51870221088345,0.552893192629787,0,0,1.38248880179171,0.907500675235638,SGK3
Epithelium Development (GO:0060429),1/154,0.521005993673017,0.554457421838218,0,0,1.37338339591156,0.895437367311009,STAT1
Peptidyl-Serine Phosphorylation (GO:0018105),1/158,0.530112516790228,0.563244549089617,0,0,1.33812169670687,0.84926034360726,SGK3
Regulation Of Macromolecule Metabolic Process (GO:0060255),1/162,0.539047696362359,0.569997803330533,0,0,1.30461213162416,0.806186660346948,CDK6
Protein Autophosphorylation (GO:0046777),1/162,0.539047696362359,0.569997803330533,0,0,1.30461213162416,0.806186660346948,EIF2AK2
Mitochondrion Organization (GO:0007005),1/162,0.539047696362359,0.569997803330533,0,0,1.30461213162416,0.806186660346948,IFIT2
Negative Regulation Of Cell Migration (GO:0030336),1/163,0.541255093975425,0.571420584881698,0,0,1.29649330181245,0.795871326831253,IFITM1
DNA Damage Response (GO:0006974),2/384,0.547186281059828,0.576509779505377,0,0,1.09908236221359,0.662709278194769,IRF7;TNFSF13B
Peptidyl-Serine Modification (GO:0018209),1/166,0.54781472260692,0.576509779505377,0,0,1.27272727272727,0.765950368444002,SGK3
Positive Regulation Of Multicellular Organismal Process (GO:0051240),2/387,0.551417574222411,0.579381698430203,0,0,1.09035050970535,0.649045216124992,EIF2AK2;TAPT1
Generation Of Neurons (GO:0048699),1/172,0.560656808735188,0.588157380049731,0,0,1.22769690182904,0.710402281783288,CDK6
Regulation Of Neuron Projection Development (GO:0010975),1/174,0.564856783249251,0.590694080905762,0,0,1.21338088795966,0.693062609673571,GFI1
Positive Regulation Of Cellular Biosynthetic Process (GO:0031328),1/174,0.564856783249251,0.590694080905762,0,0,1.21338088795966,0.693062609673571,IRS1
Phosphate-Containing Compound Metabolic Process (GO:0006796),1/184,0.585268064320003,0.611075160069546,0,0,1.1464945936519,0.614160308487262,INPP1
Negative Regulation Of Macromolecule Metabolic Process (GO:0010605),1/186,0.589235157741466,0.614249857834264,0,0,1.13398504887867,0.599798627844104,PARP9
Regulation Of Signal Transduction (GO:0009966),1/193,0.602826566790434,0.627431732781881,0,0,1.0922539893617,0.552817859603227,PLSCR1
Regulation Of Programmed Cell Death (GO:0043067),1/195,0.606627426918035,0.630398094117017,0,0,1.08088396578197,0.540269550094128,STAT1
Positive Regulation Of Protein Metabolic Process (GO:0051247),1/196,0.608514337922192,0.631369336529598,0,0,1.07528641571195,0.534132187060636,TNFSF13B
Golgi Vesicle Transport (GO:0048193),1/197,0.61039229271493,0.632328265734373,0,0,1.06974598349978,0.528083769389278,PGAP1
Regulation Of Cell Migration (GO:0030334),2/434,0.614094218564304,0.635170775207696,0,0,0.969384707287933,0.472678683832125,IFITM1;SGK3
Regulation Of Translation (GO:0006417),1/202,0.619649187949352,0.639918086620593,0,0,1.04287075261988,0.499119805783686,EIF2AK2
Regulation Of MAPK Cascade (GO:0043408),1/204,0.623290709444953,0.642677667748062,0,0,1.03249135310764,0.488102275781048,EIF2AK2
Regulation Of Nucleic Acid-Templated Transcription (GO:1903506),2/452,0.636287658787179,0.655060120770031,0,0,0.929749103942652,0.420343776268428,MYB;BRCA2
Positive Regulation Of Transcription By RNA Polymerase II (GO:0045944),4/938,0.656717859559823,0.675044869594051,0,0,0.892815963479775,0.375429818178822,PLSCR1;STAT1;MYB;IRF7
Regulation Of Cell Growth (GO:0001558),1/227,0.662768045890782,0.680209310256329,0,0,0.926332140839767,0.381028389740136,SGK3
Chromatin Remodeling (GO:0006338),1/228,0.664388280983464,0.68081828484086,0,0,0.92220451776174,0.377078858751476,SATB1
Negative Regulation Of Multicellular Organismal Process (GO:0051241),1/231,0.669202913383426,0.684693721563598,0,0,0.910037002775208,0.365532703105073,BRCA2
Regulation Of I-kappaB kinase/NF-kappaB Signaling (GO:0043122),1/232,0.670792553452455,0.685262654759595,0,0,0.906051395413098,0.361782109130868,STAT1
Positive Regulation Of Developmental Process (GO:0051094),1/233,0.672374634505767,0.685822127195883,0,0,0.902100146735143,0.358079273187326,TAPT1
Regulation Of Autophagy (GO:0010506),1/241,0.684763392116365,0.697385758791321,0,0,0.871675531914894,0.330087758252468,LAMP3
Regulation Of ERK1 And ERK2 Cascade (GO:0070372),1/244,0.689288685958786,0.70091778955625,0,0,0.860782768584187,0.320293052969766,GBP1
Positive Regulation Of DNA-binding Transcription Factor Activity (GO:0051091),1/246,0.692269777019097,0.702871151858594,0,0,0.853669127225358,0.313962045883133,EIF2AK2
Regulation Of DNA-templated Transcription (GO:0006355),8/1922,0.703906988777966,0.713593782201516,0,0,0.864338990379418,0.303477241587469,SATB1;STAT1;GFI1;MYB;IRF7;CD38;BRCA2;PARP9
Negative Regulation Of Signal Transduction (GO:0009968),1/267,0.72191223904346,0.730729487764601,0,0,0.785434330507119,0.255935111872442,IRS1
Chromatin Organization (GO:0006325),1/268,0.723251021784583,0.730968639395089,0,0,0.782452785082477,0.253513859163298,SATB1
Positive Regulation Of Apoptotic Process (GO:0043065),1/270,0.725909484230141,0.732538794588408,0,0,0.776556197105117,0.248754207246632,IFIT2
Positive Regulation Of Cell Migration (GO:0030335),1/272,0.728542675466188,0.73407871403356,0,0,0.770746643636649,0.24410245668129,GAB1
Regulation Of Intracellular Signal Transduction (GO:1902531),1/297,0.759419697619544,0.763042628453694,0,0,0.704751293847038,0.193948044545821,GBP1
Regulation Of Transcription By RNA Polymerase II (GO:0006357),8/2028,0.759589946876981,0.763042628453694,0,0,0.814157277796745,0.223874147104591,PLSCR1;IFI27;SATB1;STAT1;GFI1;MYB;IRF7;PARP9
Positive Regulation Of MAPK Cascade (GO:0043410),1/310,0.774075077638861,0.776417211005393,0,0,0.674653997108036,0.172769720491478,EIF2AK2
Positive Regulation Of Cellular Process (GO:0048522),2/594,0.777869595581545,0.779044625182121,0,0,0.701576576576577,0.17623349898531,IRS1;IL6ST
Nervous System Development (GO:0007399),1/433,0.875604136259221,0.875604136259221,0,0,0.479536052009456,0.0637021395237169,BTBD3
